SEC Filing | Genpact Ltd

Large accelerated filer

Accelerated filer

Non-accelerated filer

¨ (Do not check if a smaller reporting company)

Smaller reporting company

View:

Download DOC

Download PDF

Download XLS

Download XBRL

Form 10-Q

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

Form 10-Q

(Mark One)

x	Quarterly Report Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934

For the Quarterly Period ended June 30, 2014

¨	Transition Report Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934

For the Transition Period from to

Commission file number: 001-33626

GENPACT LIMITED

(Exact name of registrant as specified in its charter)

Bermuda

98-0533350

(State or other jurisdiction of

incorporation or organization)

(I.R.S. Employer

Identification No.)

Canon’s Court

22 Victoria Street

Hamilton HM12

Bermuda

(441) 295-2244

(Address, including zip code, and telephone number, including area code, of registrant’s principal executive office)

Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days. Yes x No ¨

Indicate by check mark whether the registrant has submitted electronically and posted on its corporate Web site, if any, every Interactive Data File required to be submitted and posted pursuant to Rule 405 of Regulation S-T (§232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit and post such files). Yes x No ¨

Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer or a smaller reporting company. See definition of “accelerated filer”, “large accelerated filer” and “smaller reporting company” in Rule 12b-2 of the Exchange Act. (Check one):

Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act). Yes ¨ No x

The number of the registrant’s common shares, par value $0.01 per share, outstanding as of August 1, 2014 was 216,328,904.

TABLE OF CONTENTS


	Item No.		Page No.
PART I		Financial Statements
	1.	Unaudited Consolidated Financial Statements
		Consolidated Balance Sheets as of December 31, 2013 and June 30, 2014		1
		Consolidated Statements of Income for the three months and six months ended June 30, 2013 and 2014		3
		Consolidated Statements of Comprehensive Income (Loss) for the three months and six months ended June 30, 2013 and 2014		4
		Consolidated Statements of Equity for the six months ended June 30, 2013 and 2014		5
		Consolidated Statements of Cash Flows for the six months ended June 30, 2013 and 2014		7
		Notes to the Consolidated Financial Statements		8
	2.	Management’s Discussion and Analysis of Financial Condition and Results of Operations		30
	3.	Quantitative and Qualitative Disclosures About Market Risk		47
	4.	Controls and Procedures		47

PART II		Other Information
	1.	Legal Proceedings		47
	1A.	Risk Factors		48
	2.	Unregistered Sales of Equity Securities and Use of Proceeds		49
	3.	Defaults upon Senior Securities		49
	5.	Other Information		49
	6.	Exhibits		49
SIGNATURES				51

GENPACT LIMITED AND ITS SUBSIDIARIES

Consolidated Balance Sheets

(Unaudited)

(In thousands, except per share data and share count)


	Notes		As of December 31, 2013		As of June 30, 2014
Assets
Current assets
Cash and cash equivalents		4	$	571,276	$	376,802
Accounts receivable, net		5		504,714		531,093
Accounts receivable from related party, net		5, 21		403		24
Deferred tax assets		20		60,638		44,118
Prepaid expenses and other current assets				139,113		189,018

Total current assets			$	1,276,144	$	1,141,055
Property, plant and equipment, net		8		173,204		176,282
Deferred tax assets		20		89,305		65,866
Investment in equity affiliates				384		450
Intangible assets, net		9		99,116		122,395
Goodwill		9		953,849		1,072,070
Other assets				97,365		110,062

Total assets			$	2,689,367	$	2,688,180

See accompanying notes to the Consolidated Financial Statements.

GENPACT LIMITED AND ITS SUBSIDIARIES

Consolidated Balance Sheets

(Unaudited)

(In thousands, except per share data and share count)


	Notes		As of December 31, 2013			As of June 30, 2014
Liabilities and equity
Current liabilities
Short-term borrowings		10		—		$	175,000
Current portion of long-term debt		11		4,263			4,275
Current portion of capital lease obligations				1,405			1,575
Accounts payable				18,412			17,490
Income taxes payable		20		15,007			35,148
Deferred tax liabilities		20		614			616
Accrued expenses and other current liabilities				421,992			406,143

Total current liabilities			$	461,693		$	640,247
Long-term debt, less current portion		11		653,601			651,451
Capital lease obligations, less current portion				2,657			2,993
Deferred tax liabilities		20		4,464			5,431
Other liabilities				242,884			182,253

Total liabilities			$	1,365,299		$	1,482,375

Shareholders’ equity
Preferred shares, $0.01 par value, 250,000,000 authorized, none issued				—			—
Common shares, $0.01 par value, 500,000,000 authorized, 231,262,576 and 216,314,379 issued and outstanding as of December 31, 2013 and June 30, 2014, respectively				2,310			2,160
Additional paid-in capital				1,268,344			1,275,127
Retained earnings				511,699			306,301
Accumulated other comprehensive income (loss)				(459,614	)		(377,887	)

Genpact Limited shareholders’ equity			$	1,322,739		$	1,205,701
Noncontrolling interest				1,329			104

Total equity			$	1,324,068		$	1,205,805
Commitments and contingencies		22

Total liabilities and equity			$	2,689,367		$	2,688,180

See accompanying notes to the Consolidated Financial Statements.

GENPACT LIMITED AND ITS SUBSIDIARIES

Consolidated Statements of Income

(Unaudited)

(In thousands, except per share data and share count)


			Three months ended June 30,						Six months ended June 30,
	Notes		2013			2014			2013			2014
Net revenues
Net revenues from services—others			$	534,614		$	561,540		$	1,038,271		$	1,089,659
Net revenues from services—related party		21		190			71			381			142

Total net revenues				534,804			561,611			1,038,652			1,089,801

Cost of revenue
Services		16, 21		332,714			340,125			644,440			664,414

Total cost of revenue				332,714			340,125			644,440			664,414

Gross profit			$	202,090		$	221,486		$	394,212		$	425,387
Operating expenses:
Selling, general and administrative expenses		17, 21		118,403			142,715			231,627			265,213
Amortization of acquired intangible assets		9		6,185			6,610			11,736			12,628
Other operating (income) expense, net		18		(486	)		(890	)		(1,088	)		(2,752	)

Income from operations			$	77,988		$	73,051		$	151,937		$	150,298
Foreign exchange (gains) losses, net				(17,184	)		3,829			(13,802	)		7,422
Other income (expense), net		19		(10,539	)		(6,505	)		(15,650	)		(13,038	)

Income before equity-method investment activity, net and income tax expense			$	84,633		$	62,717		$	150,089		$	129,838
Equity-method investment activity, net				(63	)		(34	)		(107	)		(54	)

Income before income tax expense			$	84,696		$	62,751		$	150,196		$	129,892
Income tax expense		20		19,234			13,851			36,482			30,139

Net income			$	65,462		$	48,900		$	113,714		$	99,753
Net income attributable to noncontrolling interest				1,586			(84	)		3,101			156

Net income attributable to Genpact Limited shareholders			$	63,876		$	48,984		$	110,613		$	99,597

Net income available to Genpact Limited common shareholders		15	$	63,876		$	48,984		$	110,613		$	99,597
Earnings per common share attributable to Genpact Limited common shareholders		15
Basic			$	0.28		$	0.23		$	0.48		$	0.44
Diluted			$	0.27		$	0.22		$	0.47		$	0.43
Weighted average number of common shares used in computing earnings per common share attributable to Genpact Limited common shareholders
Basic				229,237,503			217,541,960			228,232,364			224,817,938
Diluted				235,329,303			221,509,867			234,475,027			229,392,759

See accompanying notes to the Consolidated Financial Statements.

GENPACT LIMITED AND ITS SUBSIDIARIES

Consolidated Statements of Comprehensive Income (Loss)

(Unaudited)

(In thousands)


	Three months ended June 30,										Six months ended June 30,
	2013					2014					2013					2014
	Genpact Limited Shareholders			Non controlling interest		Genpact Limited Shareholders		Non controlling interest			Genpact Limited Shareholders			Non controlling interest		Genpact Limited Shareholders		Non controlling interest
Net Income	$	63,876		$	1,586	$	48,984	$	(84	)	$	110,613		$	3,101	$	99,597	$	156
Other comprehensive income:
Currency translation adjustments		(93,571	)		47		398		(5	)		(91,738	)		34		18,991		(10	)
Net income (loss) on cash flow hedging derivatives, net of taxes (Note 7)		(48,978	)		—		24,588		—			(29,448	)		—		62,580		—
Retirement benefits, net of taxes		—			—		76		—			—			—		156		—

Other comprehensive income (loss)	$	(142,549	)	$	47	$	25,062	$	(5	)	$	(121,186	)	$	34	$	81,727	$	(10	)

Comprehensive income (loss)	$	(78,673	)	$	1,633	$	74,046	$	(89	)	$	(10,573	)	$	3,135	$	181,324	$	146

See accompanying notes to the Consolidated Financial Statements.

GENPACT LIMITED AND ITS SUBSIDIARIES

Consolidated Statements of Equity

(Unaudited)

(In thousands, except share count)


	Genpact Limited Shareholders
	Common shares				Additional Paid-in Capital			Retained Earnings		Accumulated Other Comprehensive Income (Loss)			Noncontrolling interest			Total Equity
	No. of Shares		Amount		Additional Paid-in Capital			Retained Earnings		Accumulated Other Comprehensive Income (Loss)			Noncontrolling interest			Total Equity
Balance as of January 1, 2013		225,480,172	$	2,253	$	1,202,448		$	281,982	$	(318,272	)	$	3,370		$	1,171,781
Issuance of common shares on exercise of options (Note 13)		3,184,358		32		26,548			—		—			—			26,580
Issuance of common shares under the employee stock purchase plan (Note 13)		53,671		1		897			—		—			—			898
Net settlement on vesting of restricted share units (Note 13)		299,441		3		(5,129	)		—		—			—			(5,126	)
Net settlement on vesting of performance units (Note 13)		496,112		5		(2,400	)		—		—			—			(2,395	)
Disposition of noncontrolling interest		—		—		—			—		—			(1,055	)		(1,055	)
Distribution to noncontrolling interest		—		—		—			—		—			(3,242	)		(3,242	)
Stock-based compensation expense (Note 13)		—		—		16,619			—		—			—			16,619
Comprehensive income:
Net income		—		—		—			110,613		—			3,101			113,714
Other comprehensive income		—		—		—			—		(121,186	)		34			(121,152	)

Balance as of June 30, 2013		229,513,754	$	2,294	$	1,238,983		$	392,595	$	(439,458	)	$	2,208		$	1,196,622

See accompanying notes to the Consolidated Financial Statements.

GENPACT LIMITED AND ITS SUBSIDIARIES

Consolidated Statements of Equity

(Unaudited)

(In thousands, except share count)


	Genpact Limited Shareholders
	Common shares						Additional Paid-in Capital			Retained Earnings			Accumulated Other Comprehensive Income (Loss)			Noncontrolling interest			Total Equity
	No. of Shares			Amount			Additional Paid-in Capital			Retained Earnings			Accumulated Other Comprehensive Income (Loss)			Noncontrolling interest			Total Equity
Balance as of January 1, 2014		231,262,576		$	2,310		$	1,268,344		$	511,699		$	(459,614	)	$	1,329		$	1,324,068
Net settlement on issuance of common shares on exercise of options (Note 13)		1,227,962			12			1,095			—			—			—			1,107
Issuance of common shares under the employee stock purchase plan (Note 13)		77,556			1			1,170			—			—			—			1,171
Net settlement on vesting of restricted share units (Note 13)		125,188			1			(861	)		—			—			—			(860	)
Net settlement on vesting of performance units (Note 13)		913,939			9			(6,500	)		—			—			—			(6,491	)
Stock purchased and retired		(17,292,842	)		(173	)		—			(302,452	)		—			—			(302,625	)
Expenses related to stock purchase		—			—			—			(2,543	)		—			—			(2,543	)
Distribution to noncontrolling interest		—			—			—			—			—			(1,371	)		(1,371	)
Stock-based compensation expense (Note 13)		—			—			11,879			—			—			—			11,879
Comprehensive income:
Net income		—			—			—			99,597			—			156			99,753
Other comprehensive income		—			—			—			—			81,727			(10	)		81,717

Balance as of June 30, 2014		216,314,379		$	2,160		$	1,275,127		$	306,301		$	(377,887	)	$	104		$	1,205,805

See accompanying notes to the Consolidated Financial Statements.

GENPACT LIMITED AND ITS SUBSIDIARIES

Consolidated Statements of Cash Flows

(Unaudited)

(In thousands)


	Six months ended June 30,
	2013			2014
Operating activities
Net income attributable to Genpact Limited shareholders	$	110,613		$	99,597
Net income attributable to noncontrolling interest		3,101			156
Net income	$	113,714		$	99,753
Adjustments to reconcile net income to net cash provided by (used for) operating activities:
Depreciation and amortization		27,318			24,994
Amortization of debt issue costs (including loss on extinguishment of debt)		4,392			1,610
Amortization of acquired intangible assets		11,736			12,628
Reserve for doubtful receivables		5,070			1,719
Unrealized (gain) loss on revaluation of foreign currency asset/liability		(14,067	)		(807	)
Equity-method investment activity, net		(107	)		(54	)
Stock-based compensation expense		16,619			11,879
Deferred income taxes		1,589			(322	)
Others, net		6,087			895
Change in operating assets and liabilities:
Increase in accounts receivable		(25,492	)		(15,110	)
Increase in other assets		(25,385	)		(37,870	)
Decrease in accounts payable		(3,060	)		(5,222	)
Decrease in accrued expenses and other current liabilities		(33,809	)		(7,788	)
Increase in income taxes payable		18,826			18,939
Increase (Decrease) in other liabilities		4,244			(12,178	)

Net cash provided by operating activities	$	107,675		$	93,066

Investing activities
Purchase of property, plant and equipment		(25,635	)		(29,657	)
Proceeds from sale of property, plant and equipment		283			129
Short term deposits placed		(36,769	)		—
Redemption of short term deposits		36,769			—
Payment for business acquisitions, net of cash acquired		(46,134	)		(123,701	)
Proceeds from divestiture of business, net of cash divested		(1,049	)		—

Net cash used for investing activities	$	(72,535	)	$	(153,229	)

Financing activities
Repayment of capital lease obligations		(874	)		(896	)
Proceeds from long-term debt		121,410			—
Repayment of long-term debt		(119,723	)		(3,375	)
Proceeds from Short-term borrowings		35,000			195,000
Repayment of Short-term borrowings		—			(20,000	)
Proceeds from issuance of common shares under stock-based compensation plans		27,478			8,329
Payment for net settlement of stock-based awards		(7,521	)		(14,345	)
Payment of earn-out consideration		(2,993	)		—
Cost incurred in relation to debt amendment and refinancing		(7,908	)		—
Distribution to noncontrolling interest		(3,242	)		(1,371	)
Expenses related to stock purchase		—			(2,543	)
Stock purchased and retired		—			(302,625	)

Net cash provided by (used for) financing activities	$	41,627		$	(141,826	)

Effect of exchange rate changes		(16,868	)		7,515
Net increase (decrease) in cash and cash equivalents		76,767			(201,989	)
Cash and cash equivalents at the beginning of the period		459,228			571,276

Cash and cash equivalents at the end of the period	$	519,127		$	376,802

Supplementary information
Cash paid during the period for interest	$	18,474		$	12,828
Cash paid during the period for income taxes	$	38,909		$	37,176
Property, plant and equipment acquired under capital lease obligation	$	1,385		$	1,305

GENPACT LIMITED AND ITS SUBSIDIARIES

Notes to the Consolidated Financial Statements

(Unaudited)

(In thousands, except per share data and share count)

1. Organization

Nature of Operations

The Company is a global leader in designing, transforming and running business processes and operations, including those that are complex and industry-specific. The Company’s mission is to help clients become more competitive by making their enterprises more intelligent through becoming more adaptive, innovative, globally effective and connected to their own clients. Genpact stands for Generating Impact – visible in better management of risk, regulations, costs and growth for hundreds of long-term clients, including more than 100 of the Fortune Global 500. The Company’s approach is distinctive – it offers an unbiased, agile combination of smarter processes, crystallized in its Smart Enterprise Processes (SEP^SM) proprietary framework, along with analytics and technology, which limits upfront investments and enhances future adaptability. The Company has 66,000+ employees in 25 countries with key management and corporate offices in New York City. Behind the Company’s single-minded passion for process and operational excellence is the Lean and Six Sigma heritage of a former General Electric division that has served GE businesses for more than 16 years.

Prior to December 30, 2004, the business of the Company was conducted through various entities and divisions of the General Electric Company (“GE”). On December 30, 2004, in a series of transactions referred to as the “2004 Reorganization,” GE transferred such operations to the Company. In August 2007, the Company completed an initial public offering of its common shares, pursuant to which the Company and certain of its existing shareholders each sold 17,647,059 shares. On March 24, 2010, the Company completed a secondary offering of its common shares pursuant to which GE’s shareholding in the Company decreased to 9.1% and it ceased to be a significant shareholder, although it continued to be a related party. During the year ended December 31, 2012, GE’s shareholding declined to less than 5.0%, as a result of which GE is no longer considered a related party.

On December 14, 2012, a secondary offering of the Company’s common shares by affiliates of General Atlantic (“GA”) and Oak Hill Capital Partners (“OH”) was completed. Upon the completion of the secondary offering, GA and OH each owned approximately 2.4% of the Company’s common shares outstanding, and they ceased to be significant shareholders and related parties.

2012 Recapitalization

On August 1, 2012, affiliates of GA and OH entered into an agreement to sell 67,750,678 common shares of the Company to Glory Investments A Limited, formerly known as South Asia Private Investments, an affiliate of Bain Capital Investors, LLC (“Bain Capital”). On October 25, 2012, Bain Capital and its affiliated assignees, along with two additional co-investors (RGIP, LLC, an investor in certain investment funds which are affiliated with Bain Capital, and Twickenham Investment Private Limited, an affiliate of the Government of Singapore Investment Corporation Private Limited), completed the purchase of the Company common shares covered by the share purchase agreement.

On August 30, 2012, the Company terminated its previous credit facility of $380,000 and entered into a new credit facility of $925,000. Net proceeds from the credit facility along with cash on hand were partially used to fund the payment of a special cash dividend in the amount of $2.24 per share, or $501,620 in aggregate, which was declared by the Company’s board of directors on August 30, 2012, and paid on September 24, 2012 to holders of record as of September 10, 2012. The share purchase transaction described above, the entry into a new credit facility and the payment of the special cash dividend are referred to collectively as the “2012 Recapitalization.”

GENPACT LIMITED AND ITS SUBSIDIARIES

Notes to the Consolidated Financial Statements

(Unaudited)

(In thousands, except per share data and share count)

2. Summary of significant accounting policies

(a) Basis of preparation and principles of consolidation

The unaudited interim consolidated financial statements have been prepared in accordance with U.S. generally accepted accounting principles (U.S. GAAP) for interim financial information and the rules and regulations of the Securities and Exchange Commission for reporting on Form 10-Q. Accordingly, they do not include certain information and note disclosures required by generally accepted accounting principles for annual financial reporting and should be read in conjunction with the consolidated financial statements included in the Company’s Annual Report on Form 10-K for the year ended December 31, 2013.

The unaudited interim consolidated financial statements reflect all adjustments that management considers necessary for a fair presentation of the results of operations for these periods. The results of operations for the interim periods are not necessarily indicative of the results for the full year.

The accompanying unaudited interim consolidated financial statements have been prepared on a consolidated basis and reflect the financial statements of Genpact Limited and all of its subsidiaries that are more than 50% owned and controlled. When the Company does not have a controlling interest in an entity, but exerts significant influence on the entity, the Company applies the equity method of accounting. All intercompany transactions and balances are eliminated in consolidation.

The noncontrolling interest disclosed in the accompanying unaudited interim consolidated financial statements represents the noncontrolling partners’ interest in the operation of Genpact Netherlands B.V. and the profits or losses associated with such noncontrolling interest. The noncontrolling partners of Genpact Netherlands B.V. are individually liable for the tax obligations on their shares of profit as it is a partnership and, accordingly, noncontrolling interest relating to Genpact Netherlands B.V. has been computed prior to tax and disclosed accordingly in the unaudited interim Consolidated Statements of Income.

(b) Use of estimates

The preparation of consolidated financial statements in accordance with U.S. GAAP requires management to make estimates and assumptions that affect the amounts reported in the consolidated financial statements. Significant items subject to such estimates and assumptions include the useful lives of property, plant and equipment, the carrying amount of property, plant and equipment, intangibles and goodwill, reserves for doubtful receivables, valuation allowances for deferred tax assets, the valuation of derivative financial instruments, measurements of stock-based compensation, assets and obligations related to employee benefits, and income tax uncertainties and other contingencies. Management believes that the estimates used in the preparation of the consolidated financial statements are reasonable. Although these estimates are based upon management’s best knowledge of current events and actions, actual results could differ from these estimates. Any changes in estimates are adjusted prospectively in the Company’s consolidated financial statements.

(c) Business combinations, goodwill and other intangible assets

The Company accounts for its business combinations by recognizing the identifiable tangible and intangible assets acquired and liabilities assumed, and any noncontrolling interest in the acquired business, measured at their acquisition date fair values. Contingent consideration is included within the acquisition cost and is recognized at its fair value on the acquisition date. A liability resulting from contingent consideration is remeasured to fair value as of each reporting date until the contingency is resolved. Changes in fair value are recognized in earnings. All assets and liabilities of the acquired businesses, including goodwill, are assigned to reporting units. Acquisition related costs are expensed as incurred under Selling, General and Administrative Expenses.

Goodwill represents the cost of acquired businesses in excess of the fair value of identifiable tangible and intangible net assets purchased. Goodwill is not amortized but is tested for impairment at least on an annual basis on December 31, based on a number of factors, including operating results, business plans and future cash flows. The Company performs an assessment of qualitative factors to determine whether the existence of events or circumstances leads to a determination that it is more likely than not that the fair value of a reporting unit is less than its carrying amount. Based on the assessment of events or circumstances, the Company performs the quantitative assessment of goodwill impairment if it determines that it is more likely than not that the fair value of a reporting unit is less than its carrying amount. If, based on the quantitative impairment analysis, the carrying value of the goodwill of the reporting unit exceeds the fair value of that goodwill, an impairment loss is recognized in an amount equal to the excess. In addition, the Company performs the qualitative assessment of goodwill impairment between annual tests if an event occurs or circumstances change that would more likely than not reduce the fair value of the reporting unit below its carrying amount. See Note 9 for information and related disclosures.

GENPACT LIMITED AND ITS SUBSIDIARIES

Notes to the Consolidated Financial Statements

(Unaudited)

(In thousands, except per share data and share count)

2. Summary of significant accounting policies (Continued)

Intangible assets acquired individually or with a group of other assets or in a business combination are carried at cost less accumulated amortization based on their estimated useful lives as follows:


Customer-related intangible assets			1-14 years
Marketing-related intangible assets			1-10 years
Contract-related intangible assets			1 year
Other intangible assets			3-9 years

Intangible assets are amortized over their estimated useful lives using a method of amortization that reflects the pattern in which the economic benefits of the intangible assets are consumed or otherwise realized.

In business combinations, where the fair value of identifiable tangible and intangible net assets purchased exceeds the cost of the acquired business, the Company recognizes the resulting gain under “Other operating (income) expense, net” in the Consolidated Statements of Income.

(d) Financial instruments and concentration of credit risk

Financial instruments that potentially subject the Company to concentration of credit risk are reflected principally in cash and cash equivalents, short term deposits, derivative financial instruments and accounts receivable. The Company places its cash and cash equivalents and derivative financial instruments with corporations and banks with high investment grade ratings, limits the amount of credit exposure with any one corporation or bank and conducts ongoing evaluations of the creditworthiness of the corporations and banks with which it does business. To reduce its credit risk on accounts receivable, the Company conducts ongoing credit evaluations of its clients. GE accounted for 28% and 25% of receivables as of December 31, 2013 and June 30, 2014, respectively. GE accounted for 23% and 21% of revenues for the six months and three months ended June 30, 2013 and 2014, respectively.

(e) Recently adopted accounting pronouncements

The authoritative bodies release standards and guidance which are assessed by management for impact on the Company’s consolidated financial statements.

The following recently released accounting standards have been adopted by the Company. Adoption of these standards did not have a material impact on the Company’s consolidated results of operations, cash flows, financial position or disclosures:

•

Effective January 1, 2014, the Company adopted FASB ASU 2013-05, Foreign Currency Matters (Topic 830): Parent’s Accounting for the Cumulative Translation Adjustment upon De-recognition of Certain Subsidiaries or Groups of Assets within a Foreign Entity or of an Investment in a Foreign Entity (“ASU 2013-05”). This new guidance requires that the parent release any related cumulative translation adjustment into net income only if the sale or transfer results in the complete or substantially complete liquidation of the foreign entity in which the subsidiary or group of assets had resided.

•

Effective January 1, 2014, the Company adopted FASB ASU 2013-11, Income Taxes (Topic 740): Presentation of an Unrecognized Tax Benefit When a Net Operating Loss Carryforward, a Similar Tax Loss, or a Tax Credit Carryforward Exists (“ASU 2013-11”). This new guidance requires an entity to present an unrecognized tax benefit, or a portion of an unrecognized tax benefit, as a reduction to a deferred tax asset for a net operating loss carryforward, a similar tax loss, or a tax credit carryforward, except as follows: to the extent a net operating loss carryforward, a similar tax loss, or a tax credit carryforward is not available at the reporting date under the tax law of the applicable jurisdiction to settle any additional income taxes that would result from the disallowance of a tax position or the tax law of the applicable jurisdiction does not require the entity to use, and the entity does not intend to use, the deferred tax asset for such purpose, the unrecognized tax benefit should be presented in the financial statements as a liability and should not be combined with deferred tax assets.

(f) Reclassification

Certain reclassifications have been made in the consolidated financial statements of prior periods to conform to the classification used in the current period. The impact of such reclassifications on the consolidated financial statements is not material.

GENPACT LIMITED AND ITS SUBSIDIARIES

Notes to the Consolidated Financial Statements

(Unaudited)

(In thousands, except per share data and share count)

3. Business acquisitions

A. Acquisitions

Pharmalink Consulting Limited and Pharmalink Consulting Inc.

On May 29, 2014, the Company acquired 100% of the outstanding equity interest in each of Pharmalink Consulting Limited, a company incorporated under the laws of England and Wales, and Pharmalink Consulting Inc., a California corporation, (collectively referred to as “Pharmalink”) for cash consideration of $126,483, subject to adjustment for net debt and working capital. The acquisition agreement provides for contingent earn-out consideration (ranging from $0 to $27,405) which had an estimated fair value of $12,730 as of the acquisition date, based on gross profits and order bookings of sustainable outsourcing contracts for the period from June 1, 2014 to June 30, 2016. The total consideration paid at closing for the Company’s acquisition of Pharmalink was $123,701, net of cash acquired of $2,200.

Pharmalink is a provider of regulatory affairs services to the life sciences industry. With this acquisition, the Company adds regulatory consulting, outsourcing and operations capabilities for clients in the life sciences industry.

The acquisition of Pharmalink has been accounted for under the acquisition method of accounting in accordance with ASC 805, Business Combinations. The assets and liabilities of Pharmalink are recorded at fair value as of the date of the acquisition. As of the date of these financial statements, the purchase consideration and the allocation for the acquisition are pending final adjustment for working capital and net debt in accordance with the terms of acquisition agreement. The preliminary estimated purchase consideration for Pharmalink is $138,631 including the fair value of earn-out consideration and a preliminary adjustment for working capital and net debt. Further, the Company is evaluating certain tax positions with respect to this acquisition which, when determined, may result in the recognition of additional assets and liabilities as of the acquisition date. Changes to the preliminary recorded assets and liabilities may result in a corresponding adjustment to goodwill. The measurement period will not exceed one year from the acquisition date.

The following table summarizes the preliminary allocation of the preliminary estimated purchase price based on the fair value of the assets acquired and the liabilities assumed as of the date of acquisition:


Preliminary estimated purchase price	$	138,631
Acquisition related costs included in selling, general and administrative expenses as incurred		1,977
Recognized amounts of identifiable assets acquired and liabilities assumed
Net assets acquired (excluding intangible assets and deferred tax asset/(liability), net)		7,174
Intangible assets		29,923
Deferred tax asset/(liability), net		(8,419	)
Total identifiable net assets acquired		28,678
Goodwill	$	109,953
Total	$	138,631

GENPACT LIMITED AND ITS SUBSIDIARIES

Notes to the Consolidated Financial Statements

(Unaudited)

(In thousands, except per share data and share count)

3. Business acquisitions (continued)

The fair value of the net assets acquired includes trade receivables with a fair value of $11,897. The gross amount due is $12,075, of which $178 is expected to be uncollectible. Goodwill, representing the excess of the preliminary estimated purchase price over the net assets acquired, has been allocated to the India reporting unit and is not deductible for tax purposes. The amortizable intangible assets acquired are being amortized over their estimated useful lives using a method of amortization that reflects the expected pattern in which the economic benefits of the intangible assets will be consumed or otherwise realized. The intangible assets consist of customer related and marketing related intangible assets with a weighted average amortization period of 6 years.

The results of operations of Pharmalink and the fair value of its assets and liabilities are included in the Company’s Consolidated Financial Statements with effect from May 29, 2014, the date of acquisition.

B. Earn-out consideration

The terms of the acquisition agreements for certain business acquisitions provided for payment of additional earn-out consideration if certain future events or conditions are met. These earn-outs were recorded as liabilities based on their fair values as of the acquisition dates. The Company evaluates the fair value of earn-out consideration for the respective acquisitions for changes at each reporting period and records the corresponding changes in “Other operating (income) expense, net” in the Consolidated Statements of Income. The company recorded a decrease in the fair value of earn-out consideration for the three months ended June 30, 2013 and June 30, 2014 of $2,324 and $556 respectively, and for the six months ended June 30, 2013 and June 30, 2014 of $2,271 and $2,198 respectively.

GENPACT LIMITED AND ITS SUBSIDIARIES

Notes to the Consolidated Financial Statements

(Unaudited)

(In thousands, except per share data and share count)

4. Cash and cash equivalents

Cash and cash equivalents as of December 31, 2013 and June 30, 2014 comprise:


	As of December 31, 2013		As of June 30, 2014
Deposits with banks	$	123,545	$	78,797
Other cash and bank balances		447,731		298,005

Total	$	571,276	$	376,802

Cash and cash equivalents as of December 31, 2013 and June 30, 2014 include restricted cash balances of $861 and $776, respectively. Restrictions primarily consist of margin balances against bank guarantees and deposits for foreign currency advances on which the bank has created a lien.

5. Accounts receivable, net of reserve for doubtful receivables

The following table provides details of the reserve for doubtful receivables recorded by the Company:


	As of December 31, 2013			As of June 30, 2014
Opening Balance as of January 1	$	9,073		$	16,560
Additions due to acquisitions		—			178
Additions charged to cost and expense		11,420			1,719
Deductions		(3,933	)		(1,681	)

Closing Balance	$	16,560		$	16,776

Accounts receivable were $521,677 and $547,893, and the reserves for doubtful receivables were $16,560 and $16,776, resulting in net accounts receivable balances of $505,117 and $531,117, each as of December 31, 2013 and June 30, 2014, respectively. In addition, accounts receivable due after one year of $15,844 and $11,494 as of December 31, 2013 and June 30, 2014, respectively, are included under other assets in the Consolidated Balance Sheets.

Accounts receivable from related parties were $403 and $24 as of December 31, 2013 and June 30, 2014, respectively. There are no reserves for doubtful receivables in respect of amounts due from related parties.

GENPACT LIMITED AND ITS SUBSIDIARIES

Notes to the Consolidated Financial Statements

(Unaudited)

(In thousands, except per share data and share count)

6. Fair Value Measurements

The Company measures certain financial assets and liabilities, including derivative instruments, at fair value on a recurring basis. The fair value measurements of these derivative instruments were determined using the following inputs as of December 31, 2013 and June 30, 2014:


	As of December 31, 2013
	Fair Value Measurements at Reporting Date Using
			Quoted Prices in Active Markets for Identical Assets		Significant Other Observable Inputs		Significant Other Unobservable Inputs
	Total		(Level 1)		(Level 2)		(Level 3)
Assets
Derivative instruments (Note a)	$	7,963	$	—	$	7,963	$	—

Total	$	7,963	$	—	$	7,963	$	—

Liabilities
Derivative instruments (Note b)	$	213,941	$	—	$	213,941	$	—

Total	$	213,941	$	—	$	213,941	$	—


	As of June 30, 2014
	Fair Value Measurements at Reporting Date Using
			Quoted Prices in Active Markets for Identical Assets		Significant Other Observable Inputs		Significant Other Unobservable Inputs
	Total		(Level 1)		(Level 2)		(Level 3)
Assets
Derivative instruments (Note a)	$	20,827	$	—	$	20,827	$	—

Total	$	20,827	$	—	$	20,827	$	—

Liabilities
Derivative instruments (Note b)	$	131,796	$	—	$	131,796	$	—

Total	$	131,796	$	—	$	131,796	$	—

(a)	Included in prepaid expenses and other current assets and other assets in the consolidated balance sheets.

(b)	Included in accrued expenses and other current liabilities and other liabilities in the consolidated balance sheets.

The Company values its derivative instruments based on market observable inputs including both forward and spot prices for the respective currencies. The quotes are taken from an independent market database.

GENPACT LIMITED AND ITS SUBSIDIARIES

Notes to the Consolidated Financial Statements

(Unaudited)

(In thousands, except per share data and share count)

7. Derivative financial instruments

The Company is exposed to the risk of rate fluctuations on foreign currency assets and liabilities and foreign currency denominated forecasted cash flows. The Company has established risk management policies, including the use of derivative financial instruments to hedge foreign currency assets and liabilities and foreign currency denominated forecasted cash flows. These derivative financial instruments are largely deliverable and non-deliverable forward foreign exchange contracts. The Company enters into these contracts with counterparties which are banks or other financial institutions, and the Company considers the risk of non-performance by the counterparties not to be material. The forward foreign exchange contracts mature between zero and sixty-six months and the forecasted transactions are expected to occur during the same period.

The following table presents the aggregate notional principal amounts of outstanding derivative financial instruments together with the related balance sheet exposure:


	Notional principal amounts (note a)				Balance sheet exposure asset (liability) (note b)
	As of December 31, 2013		As of June 30, 2014		As of December 31, 2013			As of June 30, 2014
Foreign exchange forward contracts denominated in:
United States Dollars (sell) Indian Rupees (buy)	$	1,143,000	$	1,333,800	$	(203,822	)	$	(101,349	)
United States Dollars (sell) Mexican Peso (buy)		9,000		12,120		(268	)		90
United States Dollars (sell) Philippines Peso (buy)		52,200		81,300		(2,357	)		222
Euro (sell) United States Dollars (buy)		43,779		61,141		(2,434	)		(859	)
Euro (sell) Hungarian Forints (buy)		4,121		2,045		131			(1	)
Euro (sell) Romanian Leu (buy)		61,977		104,129		1,751			3,162
Japanese Yen (sell) Chinese Renminbi (buy)		30,731		54,983		1,970			(2,322	)
Pound Sterling (sell) United States Dollars (buy)		94,338		120,890		(4,312	)		(5,944	)
Australian Dollars (sell) United States Dollars (buy)		85,156		121,156		3,363			(3,968	)

					$	(205,978	)	$	(110,969	)

(a)

Notional amounts are key elements of derivative financial instrument agreements but do not represent the amount exchanged by counterparties and do not measure the Company’s exposure to credit or market risks. However, the amounts exchanged are based on the notional amounts and other provisions of the underlying derivative financial instrument agreements.

(b)	Balance sheet exposure is denominated in U.S. dollars and denotes the mark-to-market impact of the derivative financial instruments on the reporting date.

FASB guidance on Derivatives and Hedging requires companies to recognize all derivative instruments as either assets or liabilities at fair value in the statement of financial position. In accordance with the FASB guidance on Derivatives and Hedging, the Company designates foreign exchange forward contracts as cash flow hedges for forecasted revenues and the purchase of services. In addition to this program, the Company has derivative instruments that are not accounted for as hedges under the FASB guidance in order to hedge foreign exchange risks related to balance sheet items such as receivables and intercompany borrowings denominated in currencies other than the underlying functional currency.

The fair value of the derivative instruments and their location in the Company’s financial statements are summarized in the table below:


	Cash flow hedges				Non-designated
	As of December 31, 2013		As of June 30, 2014		As of December 31, 2013		As of June 30, 2014
Assets
Prepaid expenses and other current assets	$	6,098	$	9,979	$	—	$	75
Other assets	$	1,865	$	10,773	$	—	$	—
Liabilities
Accrued expenses and other current liabilities	$	83,667	$	65,360	$	26	$	1,028
Other liabilities	$	130,248	$	65,408	$	—	$	—

GENPACT LIMITED AND ITS SUBSIDIARIES

Notes to the Consolidated Financial Statements

(Unaudited)

(In thousands, except per share data and share count)

7. Derivative financial instruments (Continued)

Cash flow hedges

For derivative instruments that are designated and qualify as cash flow hedges, the effective portion of the gain (loss) on the derivative instrument is reported as a component of other comprehensive income (loss) and reclassified into earnings in the same period or periods during which the hedged transaction is recognized in the consolidated statements of income. Gains (losses) on the derivatives representing either hedge ineffectiveness or hedge components excluded from the assessment of effectiveness are recognized in earnings as incurred.

In connection with cash flow hedges, the gains (losses) recorded as a component of other comprehensive income (loss), or OCI, and the related tax effects are summarized below:


	Three months ended June 30,																	Six months ended June 30,
	2013								2014									2013								2014
	Before- Tax amount			Tax (Expense) or Benefit		Net of tax Amount			Before- Tax amount			Tax (Expense) or Benefit			Net of tax Amount			Before- Tax amount			Tax (Expense) or Benefit		Net of tax Amount			Before- Tax amount			Tax (Expense) or Benefit			Net of tax Amount
Opening balance	$	(134,217	)	$	49,061	$	(85,156	)	$	(146,314	)	$	50,966		$	(95,348	)	$	(163,756	)	$	59,070	$	(104,686	)	$	(205,952	)	$	72,612		$	(133,340	)

Net gains (losses) reclassified into statement of income on completion of hedged transactions		(13,645	)		5,382		(8,263	)		(12,654	)		4,472			(8,182	)		(20,885	)		8,302		(12,583	)		(25,054	)		8,828			(16,226	)
Changes in fair value of effective portion of outstanding derivatives, net		(86,801	)		29,560		(57,241	)		23,644			(7,238	)		16,406			(64,502	)		22,471		(42,031	)		70,882			(24,528	)		46,354

Gain (loss) on cash flow hedging derivatives, net		(73,156	)		24,178		(48,978	)		36,298			(11,710	)		24,588			(43,617	)		14,169		(29,448	)		95,936			(33,356	)		62,580

Closing balance as of June 30	$	(207,373	)	$	73,239	$	(134,134	)	$	(110,016	)	$	39,256		$	(70,760	)	$	(207,373	)	$	73,239	$	(134,134	)	$	(110,016	)	$	39,256		$	(70,760	)

GENPACT LIMITED AND ITS SUBSIDIARIES

Notes to the Consolidated Financial Statements

(Unaudited)

(In thousands, except per share data and share count)

7. Derivative financial instruments (Continued)

The gains or losses recognized in other comprehensive income (loss) and their effects on financial performance are summarized below:


Derivatives in Cash Flow Hedging Relationships	Amount of Gain (Loss) recognized in OCI on Derivatives (Effective Portion)					Location of Gain (Loss) reclassified from OCI into Statement of Income (Effective Portion)	Amount of Gain (Loss) reclassified from OCI into Statement of Income (Effective Portion)												Location of Gain (Loss) recognized in Income on Derivatives (Ineffective Portion and Amount excluded from Effectiveness Testing)	Amount of Gain (Loss) recognized in income on Derivatives (Ineffective Portion and Amount excluded from Effectiveness Testing)
Derivatives in Cash Flow Hedging Relationships	Six months ended June 30,						Three months ended June 30,						Six months ended June 30,							Three months ended June 30,				Six months ended June 30,
	2013			2014			2013			2014			2013			2014				2013		2014		2013		2014
Forward foreign exchange contracts	$	(64,502	)	$	70,882	Revenue	$	2,386		$	(1,832	)	$	3,367		$	(2,502	)	Foreign exchange (gains) losses, net	$	—	$	—	$	—	$	—
						Cost of revenue		(13,007	)		(8,439	)		(19,616	)		(17,837	)
						Selling, general and administrative expenses		(3,024	)		(2,383	)		(4,636	)		(4,715	)

	$	(64,502	)	$	70,882		$	(13,645	)	$	(12,654	)	$	(20,885	)	$	(25,054	)		$	—	$	—	$	—	$	—

GENPACT LIMITED AND ITS SUBSIDIARIES

Notes to the Consolidated Financial Statements

(Unaudited)

(In thousands, except per share data and share count)

7. Derivative financial instruments (Continued)

Non-designated Hedges


Derivatives not designated as hedging instruments	Location of (Gain) Loss recognized in Statement of Income on Derivatives	Amount of (Gain) Loss recognized in Statement of Income on Derivatives
		Three months ended June 30,				Six months ended June 30,
		2013		2014		2013		2014
Forward foreign exchange contracts (Note a)	Foreign exchange (gains) losses, net	$	13,586	$	290	$	9,585	$	263

		$	13,586	$	290	$	9,585	$	263

(a)

These forward foreign exchange contracts were entered into to hedge fluctuations in foreign exchange rates for recognized balance sheet items such as receivables and intercompany borrowings, and were not originally designated as hedges under FASB guidance on derivatives and hedging. Realized (gains) losses and changes in the fair value of these derivatives are recorded in foreign exchange (gains) losses, net in the consolidated statements of income.

8. Property, plant and equipment, net

Property, plant and equipment, net consist of the following:


	As of December 31, 2013			As of June 30, 2014
Property, plant and equipment, gross	$	502,893		$	531,982
Less: Accumulated depreciation and amortization		(329,689	)		(355,700	)

Property, plant and equipment, net	$	173,204		$	176,282

Depreciation expense on property, plant and equipment for the six months ended June 30, 2013 and 2014 was $23,417 and $21,657, respectively, and for the three months ended June 30, 2013 and 2014 was $11,984 and $10,909, respectively. The amount of computer software amortization for the six months ended June 30, 2013 and 2014 was $5,103, and $4,408, respectively, and for the three months ended June 30, 2013 and 2014 was $2,546 and $2,252, respectively.

The depreciation and amortization expense set forth above includes the effect of the reclassification of foreign exchange (gains) losses related to the effective portion of foreign currency derivative contracts, amounting to $1,202 and $1,071 for the six months ended June 30, 2013 and 2014, respectively, and $791 and $508 for the three months ended June 30, 2013 and 2014, respectively.

GENPACT LIMITED AND ITS SUBSIDIARIES

Notes to the Consolidated Financial Statements

(Unaudited)

(In thousands, except per share data and share count)

9. Goodwill and intangible assets

The following table presents changes in goodwill for the year ended December 31, 2013 and six months ended June 30, 2014:


	As of December 31, 2013			As of June 30, 2014
Opening balance	$	956,064		$	953,849
Goodwill relating to acquisitions consummated during the period		37,918			109,953
Goodwill relating to divestitures consummated during the period		(3,450	)		—
Impact of measurement period adjustments		(362	)		—
Effect of exchange rate fluctuations		(36,321	)		8,268

Closing balance	$	953,849		$	1,072,070

The total amount of goodwill deductible for tax purposes is $38,512 and $37,015 as of December 31, 2013 and June 30, 2014, respectively.

The Company’s intangible assets acquired either individually or with a group of other assets or in a business combination are as follows:


	As of December 31, 2013						As of June 30, 2014
	Gross carrying amount		Accumulated amortization		Net		Gross carrying amount		Accumulated amortization		Net
Customer-related intangible assets	$	288,983	$	213,878	$	75,105	$	312,061	$	222,345	$	89,716
Marketing-related intangible assets		37,919		20,545		17,374		43,626		22,320		21,306
Contract-related intangible assets		1,121		1,121		—		1,152		1,152		—
Other intangible assets		9,124		2,487		6,637		14,947		3,574		11,373

	$	337,147	$	238,031	$	99,116	$	371,786	$	249,391	$	122,395

Amortization expenses for intangible assets for the six months ended June 30, 2013 and 2014 were $11,736 and $12,628, respectively, and for the three months ended June 30, 2013 and 2014 were $6,185 and $6,610, respectively, and are disclosed in the consolidated statements of income under amortization of acquired intangible assets.

GENPACT LIMITED AND ITS SUBSIDIARIES

Notes to the Consolidated Financial Statements

(Unaudited)

(In thousands, except per share data and share count)

10. Short-term borrowings

The Company has the following borrowing facilities:

(a)

Fund-based and non-fund-based credit facilities with banks, which are available for operational requirements in the form of overdrafts, letters of credit, guarantees and short-term loans. As of December 31, 2013 and June 30, 2014, the limits available were $13,906 and $14,059, respectively, out of which $6,689 and $7,529 was utilized, constituting non-funded drawdown.

(b)

A fund-based and non-fund based revolving credit facility of $250,000, which was initially entered into in August 2012 and which was amended in June 2013 as described in note 11 below. A portion of this amount was initially used to fund the special cash dividend paid in September 2012 and for the acquisition of Jawood Business Process Solutions, LLC and Felix Software Solutions Private Limited in February 2013. As of December 31, 2013 and June 30, 2014, a total of $4,397 and $177,224, respectively, was utilized, of which $0 and $175,000, respectively, constituted funded drawdown and $4,397 and $2,224, respectively, constituted non-funded drawdown. This facility expires in August 2017. The funded drawdown amount bears interest at LIBOR plus a margin of 2.50% as of both December 31, 2013 and June 30, 2014. The unutilized amount on the facility bears a commitment fee of 0.50%. Indebtedness under these facilities is secured by certain assets of the Company, and the credit agreement contains certain covenants, including a maximum leverage covenant that becomes effective only if the revolving facility is drawn for $50,000 or more. During the six months ended June 30, 2014, the Company was in compliance with all of the financial covenants.

11. Long-term debt

In August 2012, the Company obtained credit facilities aggregating $925,000 from a consortium of financial institutions to (i) finance the repayment of the balance outstanding under the previous credit facility of $380,000, (ii) fund a portion of its special cash dividend, and (iii) for general corporate purposes of the Company and its subsidiaries, including working capital requirements. The credit agreement provides for a term loan of $675,000 and a revolving credit facility of $250,000.

In June 2013, the Company amended this credit facility. Under the amended facility, the applicable margin on the term loan and the revolving credit facility was reduced from 3.25% p.a. to 2.75% p.a. and 2.50% p.a., respectively. In addition, the LIBOR floor on the term loan was reduced from 1% to 0.75%. As of the amendment date, the gross outstanding term loan amounted to $671,625. The amendment did not result in a substantial modification of $553,589 of the outstanding term loan under the previous credit facility. In connection with the amendment, the Company extinguished $118,036 of the outstanding term loan under the previous credit facility amounting to $118,036 and obtained additional funding amounting to $121,410, increasing the total term loan outstanding to $675,000. As a result, the Company expensed $3,103, which represented a partial acceleration of the amortization of the existing unamortized debt issuance costs and an additional fee paid to the lenders in respect of the extinguished amount. The overall borrowing capacity under the revolving facility did not change. The amendment of the revolving facility resulted in the accelerated amortization of $54 relating to an existing unamortized debt issuance cost. The remaining unamortized costs and an additional third-party fee paid in connection with the amendment of the term loan and revolving facility will be amortized over the term of the term loan and revolving facility, which end on August 30, 2019 and August 30, 2017, respectively.

As of December 31, 2013 and June 30, 2014, the outstanding term loan, net of debt amortization expense of $13,761 and $12,524, was $657,864 and $655,726, respectively. As of December 31, 2013 and June 30, 2014, the term loan bears interest at LIBOR (LIBOR floor of 0.75%) plus an applicable margin of 2.75% p.a. Indebtedness under the loan agreement is secured by certain assets of the Company. The amount outstanding on the term loan as of June 30, 2014 will be repaid through quarterly payments of 0.25% of the principal amount of $675,000, and the balance will be repaid upon the maturity of the term loan on August 30, 2019.

The maturity profile of the term loan, net of debt amortization expense, is as follows:


Year ended	Amount
2014	$	2,125
2015		4,288
2016		4,306
2017		4,338
2018		4,363
2019		636,306

	$	655,726

GENPACT LIMITED AND ITS SUBSIDIARIES

Notes to the Consolidated Financial Statements

(Unaudited)

(In thousands, except per share data and share count)

12. Employee benefit plans

The Company has employee benefit plans in the form of certain statutory and other schemes covering its employees.

Defined benefit plans

In accordance with Indian law, the Company provides a defined benefit retirement plan (the “Gratuity Plan”) covering substantially all of its Indian employees. In accordance with Mexican law, the Company provides termination benefits to all of its Mexican employees. In addition, certain of the Company’s subsidiaries in the Philippines and Japan have sponsored defined benefit retirement programs.

Net defined benefit plan costs for the three months and six months ended June 30, 2013 and 2014 include the following components:


	Three months ended June 30,						Six months ended June 30,
	2013			2014			2013			2014
Service costs	$	810		$	1,226		$	1,746		$	2,416
Interest costs		436			638			887			1,257
Amortization of actuarial loss		283			81			450			159
Expected return on plan assets		(209	)		(464	)		(429	)		(911	)

Net Gratuity Plan costs	$	1,320		$	1,481		$	2,654		$	2,921

Defined contribution plans

During the three months and six months ended June 30, 2013 and 2014, the Company contributed the following amounts to defined contribution plans in various jurisdictions:


	Three months ended June 30,				Six months ended June 30,
	2013		2014		2013		2014
India	$	3,784	$	4,107	$	7,489	$	7,682
U.S.		694		1,039		1,941		2,630
U.K.		571		856		947		1,401
Hungary		6		—		12		4
China		3,413		3,381		6,882		6,918
Mexico		6		2		20		10
Morocco		21		—		51		2
South Africa		57		54		126		101
Hong Kong		5		4		11		9
Netherlands		726		641		1,082		1,270
Philippines		4		3		8		6
Singapore		3		15		6		24
Japan		445		470		966		949

Total		9,735		10,572		19,541		21,006

GENPACT LIMITED AND ITS SUBSIDIARIES

Notes to the Consolidated Financial Statements

(Unaudited)

(In thousands, except per share data and share count)

13. Stock-based compensation

The Company has issued options under the Genpact Global Holdings 2005 Plan (the “2005 Plan”), the Genpact Global Holdings 2006 Plan (the “2006 Plan”), the Genpact Global Holdings 2007 Plan (the “2007 Plan”) and the Genpact Limited 2007 Omnibus Incentive Compensation Plan (the “2007 Omnibus Plan”) to eligible persons who are employees, directors and certain other persons associated with the Company.

With respect to options granted under the 2005, 2006 and 2007 Plans before the date of adoption of the 2007 Omnibus Plan, if an award granted under any of the Plans is forfeited or otherwise expires, terminates, or is cancelled without the delivery of shares, then the shares covered by the forfeited, expired, terminated, or cancelled award will be added to the number of shares otherwise available for grant under the respective Plans.

From the date of adoption of the 2007 Omnibus Plan on July 13, 2007, the options forfeited, expired, terminated, or cancelled under any of the plans will be added to the number of shares otherwise available for grant under the 2007 Omnibus Plan. The 2007 Omnibus Plan was amended and restated on April 11, 2012 to increase the number of common shares authorized for issuance by 5,593,200 shares to 15,000,000 shares.

On August 30, 2012, the Company’s Board of Directors declared a special cash dividend of $2.24 per share. The special cash dividend resulted in an adjustment to stock-based awards under both the 2007 Omnibus Plan and the 2005 Plan. Accordingly, effective September 24, 2012, the payment date of the special cash dividend, the number of common shares authorized for issuance under the 2007 Omnibus Plan was increased by 2,544,327 shares. The number of common shares authorized for issuance under the 2005 Plan was increased by 495,915 shares.

Further, as of December 31, 2012, the number of common shares authorized for issuance under the 2007 Omnibus Plan had been increased by 6,314,496 shares as a result of the termination, expiration or forfeiture of options granted under the Company’s stock incentive plans other than the 2007 Omnibus Plan. In accordance with the anti-dilutive provisions of the 2005 Plan, 2006 Plan, 2007 Plan and 2007 Omnibus Plan, the Company adjusted both the exercise price and the number of stock-based awards outstanding as of the record date of the special cash dividend. The aggregate fair value, intrinsic value and the ratio of the exercise price to the market price were approximately equal immediately before and after the adjustments. Therefore, in accordance with the equity restructuring guidance under ASC 718, Compensation-Stock Compensation, no incremental compensation expense was recognized for the adjustment to the outstanding stock-based awards as a result of the special cash dividend.

Stock-based compensation costs relating to the foregoing plans during the six months ended June 30, 2013 and 2014 were $16,503 and $11,735, respectively, and for the three months ended June 30, 2013 and 2014 were $10,022 and $6,834, respectively. These costs have been allocated to cost of revenue and selling, general, and administrative expenses.

The following table shows the significant assumptions used in connection with the determination of the fair value of options granted in the six months ended June 30, 2013 and 2014.


	Six months ended June 30, 2013			Six months ended June 30, 2014
Dividend Yield		0	%		0	%
Expected life (in months)		84			84
Risk free rate of interest		1.55	%		2.29	%
Volatility		39.39	%		38.34	%

GENPACT LIMITED AND ITS SUBSIDIARIES

Notes to the Consolidated Financial Statements

(Unaudited)

(In thousands, except per share data and share count)

13. Stock-based compensation (Continued)

Stock Options

A summary of stock option activity during the six months ended June 30, 2014 is set out below:


	Six months ended June 30, 2014
	Shares arising out of options			Weighted average exercise price		Weighted average remaining contractual life (years)		Aggregate intrinsic value
Outstanding as of January 1, 2014		11,102,163		$	12.40		5.2		—
Granted		210,000			16.78		—		—
Forfeited		(250,673	)		19.20		—		—
Expired		(27,228	)		12.32		—		—
Exercised*		(1,577,037	)		4.54		—		20,486

Outstanding as of June 30, 2014		9,457,225		$	13.63		5.2	$	43,614

Vested as of June 30, 2014 and expected to vest thereafter (Note a)		9,165,987		$	13.37		5.2	$	43,579
Vested and Exercisable as of June 30, 2014		5,888,115		$	10.24		3.0	$	42,896
Weighted average grant date fair value of grants during the period	$	16.78

(a)	Options expected to vest reflect an estimated forfeiture rate.

*	Out of this, 1,000,000 options have been net settled upon exercise by issuing 650,925 shares (net of minimum statutory withholding taxes).

As of June 30, 2014, the total remaining unrecognized stock-based compensation cost for options expected to vest amounted to $21,080, which will be recognized over the weighted average remaining requisite vesting period of 3.5 years.

Restricted Share Units

The Company has granted restricted share units, or RSUs, under the 2007 Omnibus Plan. Each RSU represents the right to receive one common share at a future date. The fair value of each RSU is the market price of one common share of the Company on the date of the grant. The RSUs granted to date have graded vesting schedules of six months to four years. The compensation expense is recognized on a straight-line basis over the vesting term.

A summary of RSUs granted during the six months ended June 30, 2014 is set out below:


	Six months ended June 30, 2014
	Number of Restricted Share Units			Weighted Average Grant Date Fair Value
Outstanding as of January 1, 2014		871,772		$	13.96
Granted		83,778			15.12
Vested*		(131,828	)		13.92
Forfeited		(44,636	)		13.67

Outstanding as of June 30, 2014		779,086		$	14.11

Expected to vest (Note a)		718,789

(a)	RSUs expected to vest reflect an estimated forfeiture rate.

*	Vested RSUs were net settled upon vesting by issuing 81,583 shares (net of minimum statutory withholding taxes).

GENPACT LIMITED AND ITS SUBSIDIARIES

Notes to the Consolidated Financial Statements

(Unaudited)

(In thousands, except per share data and share count)

13. Stock-based compensation (Continued)

44,286 RSUs vested as of December 31, 2012, the shares in respect of which became issuable on December 31, 2013. 43,605 shares were issued in January 2014 after withholding shares to the extent of the minimum statutory withholding taxes.

61,057 RSUs vested in the year ended December 31, 2013, the shares in respect of which are issuable on December 31, 2014 after withholding shares to the extent of the minimum statutory withholding taxes.

As of June 30, 2014, the total remaining unrecognized stock-based compensation cost related to RSUs amounted to $7,516, which will be recognized over the weighted average remaining requisite vesting period of 1.3 years.

Performance Units

The Company has granted stock awards in the form of Performance Units, or PUs, under the 2007 Omnibus Plan. Each PU represents the right to receive one common share at a future date based on the Company’s performance against specified targets. PUs granted to date have vesting schedules of six months to three years. The fair value of each PU is the market price of one common share of the Company on the date of grant, and assumes that performance targets will be achieved. The PUs granted under the plan are subject to cliff or graded vesting. For awards with cliff vesting, the compensation expense is recognized on a straight-line basis over the vesting terms, and for awards with graded vesting, the compensation expense is recognized over the vesting term of each separately vesting portion. Over the performance period, the number of shares to be issued is adjusted upward or downward based upon the probability of achievement of the performance targets. The ultimate number of shares issued and the related compensation cost recognized as an expense will be based on a comparison of the final performance metrics to the specified targets.

A summary of PU activity during the six months ended June 30, 2014 is set out below:


	Six months ended June 30, 2014
	Number of Performance Units			Weighted Average Grant Date Fair Value		Maximum Shares Eligible to Receive
Outstanding as of January 1, 2014		3,913,733		$	16.44		6,149,018
Granted		1,337,750			16.78		2,729,125
Vested*		(139,930	)		12.04		(139,930	)
Forfeited**		(2,540,124	)		17.69		(2,540,124	)
Addition due to achievement of higher than target performance goals*		139,930			12.04
Reduction due to achievement of lower than maximum performance goals***							(2,095,355	)

Outstanding as of June 30, 2014		2,711,359		$	15.44		4,102,734

Expected to vest (Note a)		2,605,923

GENPACT LIMITED AND ITS SUBSIDIARIES

Notes to the Consolidated Financial Statements

(Unaudited)

(In thousands, except per share data and share count)

13. Stock-based compensation (Continued)

(a)	PUs expected to vest are based on the probable achievement of performance targets after considering an estimated forfeiture rate.

*	Represents an additional award of 122,490 and 17,440 shares for the PUs granted in March 2011 and June 2011, respectively, as a result of achievement of higher than target performance as certified by the compensation committee based on the Company’s audited financial statements.

697,853 and 432 shares, including the additional awards, were issued in March 2014 and April 2014 with respect to grants made in March 2011, and 77,619 shares, including the additional awards, were issued in March 2014 with respect to grants made in June 2011, after withholding shares to the extent of the minimum statutory withholding taxes.

Includes 251,427 shares underlying PUs granted in May 2011, 1,244,507 shares underlying PUs granted in March 2013 and 630,000 shares underlying PUs granted in May 2013, all of which were forfeited due to non-fulfillment of the performance conditions as certified by the compensation committee based on the Company’s audited financial statements.

***

Represents a reduction of 333,002 and 39,285 of the maximum shares eligible to vest for PUs granted in March 2011 and June 2011, respectively, as a result of the compensation committee’s certification of the level of achievement of the performance conditions based on the Company’s audited financial statements. Also includes a reduction of 616,568 shares for grants made in March 2013, 985,500 shares for grants made in May 2013 and 121,000 shares for grants made in May 2011, due to non-fulfillment of the performance conditions as certified by the compensation committee based on the Company’s audited financial statements.

For the PUs granted in August 2010, vesting for the year ended December 31, 2012 took place at 122.2% of the target shares, or 231,029 shares, based on the compensation committee’s certification of achievement of the performance goals for the performance period based on the Company’s audited consolidated financial statements. 138,035 shares underlying such PUs were issued in January 2014 after withholding shares to the extent of the minimum statutory withholding taxes.

As of June 30, 2014, the total remaining unrecognized stock-based compensation costs related to PUs amounted to $23,502, which will be recognized over the weighted average remaining requisite vesting period of 2.2 years.

Under the 2007 Omnibus Plan, the definition of change of control includes the acquisition by any person, corporation or other entity or group other than GA, OH, GE or any of their affiliates of 25% or more of the voting securities of the Company. The purchase by Bain Capital of Company shares from GA and OH would have constituted a change of control under the 2007 Omnibus Plan resulting in (1) accelerated vesting of the PUs granted in August 2010 to the former CEO (who since assumed the role of Non-Executive Vice-Chairman) and the PUs granted to the Company’s Chief Executive Officer in June 2011 and March 2012, (2) “double-trigger” vesting of the outstanding PUs granted in March 2010 and March 2011 based on an abbreviated performance period ending with the close of the Company’s fiscal quarter coincident with or immediately preceding the effective date of the Change of Control in the event of a termination without cause in the twenty-four months following a change of control and (3) “double-trigger” vesting of the outstanding PUs granted in March 2012 based on target performance in the event of a termination without cause in the twenty-four months following a change of control. Because the Board of Directors determined that Bain Capital’s purchase of Company shares from GA and OH was not the type of transaction intended to constitute a change of control, it amended the 2007 Omnibus Plan to provide that the contemplated transaction among Bain Capital, GA and OH would not constitute a change of control thereunder. In addition, the CEO and Non-Executive Vice-Chairman waived any accelerated vesting of their PUs and the affected employees consented to the amendment of the change of control definition. As a result of the foregoing, all such PUs will continue to vest in accordance with their original terms.

The amendment to the 2007 Omnibus Plan constituted a modification to the PUs effective as of October 25, 2012, as a result of which 123 employees were affected and an incremental compensation cost of $5,500 was determined and will be recognized over a weighted average period of 1.85 years. The incremental compensation cost due to this modification was a result of considering the original performance period in determining expected vesting as against the abbreviated performance period for 2010 and 2011 grants and vesting at target for 2012 performance grants.

GENPACT LIMITED AND ITS SUBSIDIARIES

Notes to the Consolidated Financial Statements

(Unaudited)

(In thousands, except per share data and share count)

13. Stock-based compensation (Continued)

Employee Stock Purchase Plan (ESPP)

On May 1, 2008, the Company adopted the Genpact Limited U.S. Employee Stock Purchase Plan and the Genpact Limited International Employee Stock Purchase Plan (together, the “ESPP”).

The ESPP allows eligible employees to purchase the Company’s common shares through payroll deduction at 90% of the fair value of a Company common share on the last business day of each purchase interval. The dollar amount of common shares purchased under the ESPP must not exceed the greater of 15% of the participating employee’s base salary or $25 per calendar year. With effect from September 1, 2009, the offering periods commence on the first business day in March, June, September and December of each year and end on the last business day in the subsequent May, August, November and February of each year. 4,200,000 common shares have been reserved for issuance in the aggregate over the term of the ESPP.

During the six months ended June 30, 2013 and 2014, 53,671 and 77,556 common shares, respectively, were issued under the ESPP.

The ESPP is considered compensatory under the FASB guidance on Compensation-Stock Compensation.

The compensation expense for the employee stock purchase plan is recognized in accordance with the FASB guidance on Compensation-Stock Compensation. The compensation expense for the ESPP during the six months ended June 30, 2013 and 2014 was $116 and $144, respectively, and for the three months ended June 30, 2013 and 2014 was $71 and $72, respectively, and has been allocated to cost of revenue and selling, general, and administrative expenses.

14. Capital Stock

Share Purchase

On April 8, 2014, the Company purchased 17,292,842 of its common shares at $17.50 per share for an aggregate cash amount of approximately $302,625 pursuant to the Company’s modified “Dutch Auction” self-tender offer announced on March 5, 2014. Under the terms of the offer, the Company was authorized to purchase up to $300,000 of its common shares. The number of shares accepted for purchase included the Company’s exercise of its right to upsize the offer by up to 2% of the Company’s shares then outstanding. The purchased shares have been retired.

Any purchase by the Company of its common shares is accounted for when the transaction is settled. There were no unsettled share purchases as of June 30, 2014. Shares purchased and retired are deducted to the extent of their par value from common stock and from retained earnings for the excess over par value. Direct costs incurred to acquire the shares are included in the total cost of the shares. For the six months ended June 30, 2013 and 2014, $0 and $2,543, respectively, were deducted from retained earnings as direct costs related to share purchases.

GENPACT LIMITED AND ITS SUBSIDIARIES

Notes to the Consolidated Financial Statements

(Unaudited)

(In thousands, except per share data and share count)

15. Earnings per share

The Company calculates earnings per share in accordance with FASB guidance on Earnings per Share. Basic and diluted earnings per common share give effect to the change in the number of common shares of the Company outstanding. The calculation of basic earnings per common share was determined by dividing net income available to common shareholders by the weighted average number of common shares outstanding during the respective periods. The potentially dilutive shares, consisting of outstanding options on common shares, restricted share units, performance units and common shares to be issued under the ESPP have been included in the computation of diluted net earnings per share and the weighted average number of shares outstanding, except where the result would be anti-dilutive.

The number of stock awards outstanding but not included in the computation of diluted earnings per common share because their effect was anti-dilutive is 1,749,000 and 3,416,262 for the six months ended June 30, 2013 and 2014, respectively, and 3,483,000 and 3,452,761 for the three months ended June 30, 2013 and 2014, respectively.


	Three months ended June 30,				Six months ended June 30,
	2013		2014		2013		2014
Net income available to Genpact Limited common shareholders	$	63,876	$	48,984	$	110,613	$	99,597
Weighted average number of common shares used in computing basic earnings per common share		229,237,503		217,541,960		228,232,364		224,817,938
Dilutive effect of stock-based awards		6,091,800		3,967,907		6,242,663		4,574,821

Weighted average number of common shares used in computing dilutive earnings per common share		235,329,303		221,509,867		234,475,027		229,392,759

Earnings per common share attributable to Genpact Limited common shareholders
Basic	$	0.28	$	0.23	$	0.48	$	0.44
Diluted	$	0.27	$	0.22	$	0.47	$	0.43

16. Cost of revenue

Cost of revenue consists of the following:


	Three months ended June 30,				Six months ended June 30,
	2013		2014		2013		2014
Personnel expenses	$	229,107	$	229,976	$	447,542	$	457,003
Operational expenses		91,213		99,067		172,659		185,488
Depreciation and amortization		12,394		11,082		24,239		21,923

	$	332,714	$	340,125	$	644,440	$	664,414

17. Selling, general and administrative expenses

Selling, general and administrative expenses consist of the following:


	Three months ended June 30,				Six months ended June 30,
	2013		2014		2013		2014
Personnel expenses	$	85,671	$	101,182	$	167,799	$	190,688
Operational expenses		30,596		39,454		59,547		70,383
Depreciation and amortization		2,136		2,079		4,281		4,142

	$	118,403	$	142,715	$	231,627	$	265,213

GENPACT LIMITED AND ITS SUBSIDIARIES

Notes to the Consolidated Financial Statements

(Unaudited)

(In thousands, except per share data and share count)

18. Other operating (income) expense, net


	Three months ended June 30,						Six months ended June 30,
	2013			2014			2013			2014
Other operating (income) expense	$	(554	)	$	(334	)	$	(1,209	)	$	(554	)
Provision for impairment of capital work in progress / property, plant and equipment		2,392			—			2,392			—
Change in fair value of earn-out consideration and deferred consideration (relating to business acquisitions)		(2,324	)		(556	)		(2,271	)		(2,198	)

Other operating (income) expense, net	$	(486	)	$	(890	)	$	(1,088	)	$	(2,752	)

19. Other income (expense), net

Other income (expense), net consists of the following:


	Three months ended June 30,						Six months ended June 30,
	2013			2014			2013			2014
Interest income	$	4,486		$	626		$	9,759		$	1,985
Interest expense*		(12,789	)		(7,648	)		(22,727	)		(15,409	)
Provision (created) reversed for loss on divestitures		(2,945	)		—			(3,661	)		—
Other income (expense)		709			517			979			386

Other income (expense), net	$	(10,539	)	$	(6,505	)	$	(15,650	)	$	(13,038	)

*	The six months and three months ended June 30, 2013 include $3,157, representing partial acceleration of the amortization of debt issuance costs and an additional fee paid to lenders in connection with the amendment of the credit facility as described in Note 11.

20. Income taxes

The Company determines the tax provision for interim periods using an estimate of its annual effective tax rate adjusted for discrete items, if any, that are taken into account in the relevant period. Each quarter, the Company updates its estimate of the annual effective tax rate, and if its estimated tax rate changes, the Company makes a cumulative adjustment.

As of December 31, 2013, the Company had unrecognized tax benefits amounting to $21,832, including an amount of $20,901 that, if recognized, would impact the effective tax rate.

The following table summarizes the activities related to the Company’s unrecognized tax benefits for uncertain tax positions from January 1, 2014 to June 30, 2014:


Opening Balance at January 1	$	21,832
Increase related to prior year tax positions, including recorded in acquisition accounting		1,289
Decrease related to prior year tax positions		(864	)
Effect of exchange rate changes		492

Closing Balance at June 30	$	22,749

The unrecognized tax benefits as of June 30, 2014 include an amount of $21,819 that, if recognized, would impact the effective tax rate. As of December 31, 2013 and June 30, 2014, the Company has accrued approximately $3,373 and $3,338, respectively, in interest relating to unrecognized tax benefits. During the year ended December 31, 2013 and six months ended June 30, 2014, the company recognized approximately $(50) and $(27), respectively, in interest expense. As of December 31, 2013 and June 30, 2014, the Company has accrued approximately $350 and $570, respectively, for penalties.

21. Related party transactions

The Company has entered into related party transactions with its non-consolidating affiliates. During the year ended December 31, 2013, the Company acquired the remaining equity interest in one of its non-consolidating affiliates, which is now a wholly-owned subsidiary. The Company has also entered into related party transactions with a significant shareholder and its affiliates.

The Company’s related party transactions can be categorized as follows:

Revenue from services

For the six months ended June 30, 2013 and 2014, the Company recognized net revenues of $381 and $0, respectively, and for the three months ended June 30, 2013 and 2014, the Company recognized net revenues of $190 and $0, respectively, from a client who is an affiliate of a significant shareholder of the Company.

GENPACT LIMITED AND ITS SUBSIDIARIES

Notes to the Consolidated Financial Statements

(Unaudited)

(In thousands, except per share data and share count)

21. Related party transactions (Continued)

For the six months ended June 30, 2013 and 2014, the Company recognized net revenues of $0 and $142, respectively, and for the three months ended June 30, 2013 and 2014, the Company recognized net revenues of $0 and $71, respectively, from a client who is a significant shareholder of the Company.

Cost of revenue from services

The Company purchases certain services from its non-consolidating affiliates mainly relating to training and recruitment, which are included in cost of revenue. For the six months ended June 30, 2013 and 2014, cost of revenue includes an amount of $964 and $973, respectively, and for the three months ended June 30, 2013 and 2014, cost of revenue includes an amount of $544 and $440, respectively, attributable to the cost of services from the Company’s non-consolidating affiliates.

Selling, general and administrative expenses

The Company purchases certain services from its non-consolidating affiliates mainly relating to training and recruitment, which are included in selling, general and administrative expenses. For the six months ended June 30, 2013 and 2014, selling, general and administrative expenses includes an amount of $221 and $303, respectively, and for the three months ended June 30, 2013 and 2014, selling, general and administrative expenses includes an amount of $130 and $166, respectively, attributable to the cost of services from the Company’s non-consolidating affiliates.

22. Commitments and contingencies

Capital commitments

As of December 31, 2013 and June 30, 2014, the Company has committed to spend $4,491 and $6,051, respectively, under agreements to purchase property, plant and equipment. These amounts are net of capital advances paid in respect of such purchases.

Bank guarantees

The Company has outstanding bank guarantees amounting to $11,086 and $9,753 as of December 31, 2013 and June 30, 2014, respectively. Bank guarantees are generally provided to government agencies and excise and customs authorities for the purposes of maintaining a bonded warehouse. These guarantees may be revoked by the government agencies if they suffer any losses or damage through the breach of any of the covenants contained in the agreements governing such guarantees.

Other commitments

The Company’s business process delivery centers in India are 100% export oriented units or Software Technology Parks of India (“STPI”) units under the STPI guidelines issued by the Government of India. These units are exempt from customs, central excise duties, and levies on imported and indigenous capital goods, stores, and spares. The Company has undertaken to pay custom duties, service taxes, levies, and liquidated damages payable, if any, in respect of imported and indigenous capital goods, stores, and spares consumed duty free, in the event that certain terms and conditions are not fulfilled.

Item 2.

Management’s Discussion and Analysis of Financial Condition and Results of Operations

The following discussion should be read in conjunction with our consolidated financial statements and the related notes that appear elsewhere in this Quarterly Report on Form 10-Q and in our Annual Report on Form 10-K for the year ended December 31, 2013 and with the information under the heading “Management’s Discussion and Analysis of Financial Condition and Results of Operations” in our Annual Report on Form 10-K for the year ended December 31, 2013. In addition to historical information, this discussion includes forward-looking statements and information that involve risks, uncertainties and assumptions, including but not limited to those listed below and under “Risk Factors” in this Quarterly Report on Form 10-Q and in our Annual Report on Form 10-K for the year ended December 31, 2013.

Special Note Regarding Forward-Looking Statements

We have made statements in this Quarterly Report on Form 10-Q (the “Quarterly Report”) in, among other sections, this Part 1, Item 2—“Management’s Discussion and Analysis of Financial Condition and Results of Operations” that are forward-looking statements. In some cases, you can identify these statements by forward-looking terms such as “expect”, “anticipate”, “intend”, “plan,” “believe,” “seek,” “estimate,” “could,” “may,” “shall,” “will,” “would” and variations of such words and similar expressions, or the negative of such words or similar expressions. These forward-looking statements, which are subject to risks, uncertainties and assumptions about us, may include projections of our future financial performance, which in some cases may be based on our growth strategies and anticipated trends in our business. These statements are only predictions based on our current expectations and projections about future events. There are important factors that could cause our actual results, level of activity, performance or achievements to differ materially from those expressed or implied by the forward-looking statements. In particular, you should consider the numerous risks outlined in Part II, Item 1A—“Risk Factors” in this Quarterly Report on Form 10-Q and in Part I, Item 1A—“Risk Factors” in our Annual Report on Form 10-K for the year ended December 31, 2013. These forward looking statements include, but are not limited to, statements relating to:

•

our ability to retain existing clients and contracts;

•

our ability to win new clients and engagements;

•

the expected value of the statements of work under our master service agreements;

•

our beliefs about future trends in our market;

•

political, economic or business conditions in countries where we have operations or where our clients operate;

•

expected spending on business process management and information technology services by clients;

•

foreign currency exchange rates;

•

our rate of employee attrition;

•

our effective tax rate; and

•

competition in our industry.

Factors that may cause actual results to differ from expected results include, among others:

•

our ability to grow our business and effectively manage growth and international operations while maintaining effective internal controls;

•

our dependence on revenues derived from clients in the United States and Europe;

•

our ability to hire and retain enough qualified employees to support our operations;

•

our dependence on favorable tax legislation and tax policies that may be amended in a manner adverse to us or be unavailable to us in the future;

•

our ability to maintain pricing and asset utilization rates;

•

our ability to successfully consummate or integrate strategic acquisitions;

•

increases in wages in locations in which we have operations;

•

our relative dependence on the General Electric Company (GE);

•

financing terms, including, but not limited to, changes in the London Interbank Offered Rate, or LIBOR;

•

restrictions on visas for our employees traveling to North America and Europe;

•

fluctuations in exchange rates between the U.S. dollar, the euro, U.K. pound sterling, Chinese renminbi, Hungarian forint, Japanese yen, Indian rupee, Australian dollar, Philippines peso, Guatemalan quetzal, Mexican peso, Moroccan dirham, Polish zloty, Romanian leu, South African rand, Hong Kong dollar, Singapore dollar, United Arab Emirates dirham, Brazilian real, Swiss franc, Swedish krona, Danish krone, Kenyan shilling, Czech koruna, Canadian dollar, Colombian peso, Peruvian nuevo, Taiwan dollar, Saudi Arabian riyal, Indonesian rupiah and Thai bhat;

•

our ability to retain senior management;

•

the selling cycle for our client relationships;

•

our ability to attract and retain clients and our ability to develop and maintain client relationships on attractive terms;

•

legislation in the United States or elsewhere that adversely affects the performance of business process and technology management services offshore;

•

increasing competition in our industry;

•

telecommunications or technology disruptions or breaches, or natural or other disasters;

•

our ability to protect our intellectual property and the intellectual property of others;

•

further deterioration in the global economic environment and its impact on our clients, including the bankruptcy of our clients;

•

regulatory, legislative and judicial developments, including the withdrawal of governmental fiscal incentives;

•

the international nature of our business;

•

technological innovation;

•

our ability to derive revenues from new service offerings; and

•

unionization of any of our employees.

Although we believe the expectations reflected in the forward-looking statements are reasonable at the time they are made, we cannot guarantee future results, level of activity, performance or achievements. Achievement of future results is subject to risks, uncertainties, and potentially inaccurate assumptions. Should known or unknown risks or uncertainties materialize, or should underlying assumptions prove inaccurate, actual results could differ materially from past results and those anticipated, estimated or projected. You should bear this in mind as you consider forward looking statements. We undertake no obligation to update any of these forward-looking statements after the date of this filing to conform our prior statements to actual results or revised expectations. You are advised, however, to consult any further disclosures we make on related subjects in our Form 10-K, Forms 10-Q and Form 8-K reports to the SEC.

Overview

We are a global leader in designing, transforming and running business processes and operations, including those that are complex and industry-specific. Our mission is to help clients become more competitive by making their enterprises more intelligent by becoming more adaptive, innovative, globally effective and connected to their own clients. Genpact stands for Generating Impact—visible in tighter cost management as well as better management of risk, regulations and growth for hundreds of long-term clients including more than 100 of the Fortune Global 500. Our approach is distinctive—we offer an unbiased, agile combination of smarter processes, crystallized in our Smart Enterprise Processes (SEP) proprietary framework, along with analytics and technology, which limits upfront investments and enhances future adaptability. We have a global critical mass—66,000+ employees in 25 countries with key management and corporate offices in New York City—while remaining flexible and collaborative, and a management team that drives client partnerships personally. Our history is unique—behind our single-minded passion for process and operational excellence is the Lean and Six Sigma heritage of a former General Electric division that has served GE businesses for more than 16 years.

In the quarter ended June 30, 2014, we had net revenues of $561.6 million, of which $441.8 million, or 78.7%, was from clients other than GE, which we refer to as Global Clients, with the remaining $119.8 million, or 21.3%, from GE.

In the 12 months ending June 30, 2014, Genpact grew client relationships with revenues over $5 million to 85 from 81 as of June 30, 2013. This includes client relationships with more than $15 million in annual revenue increasing to 27 from 26, and client relationships with more than $25 million in annual revenue increasing to 14 from 12.

Our registered office is located at Canon’s Court, 22 Victoria Street, Hamilton HM 12, Bermuda.

Acquisitions

In May 2014, we acquired 100% of the outstanding equity interest in each of Pharmalink Consulting Limited and Pharmalink Consulting Inc. (collectively referred to as “Pharmalink”), providers of regulatory affairs services to the life sciences industry, for cash consideration of $126.5 million, subject to adjustment for net debt and working capital. The acquisition agreement also provides for contingent earn-out consideration (ranging from $0 to $27.4 million) which had an estimated fair value of $12.7 million as of the acquisition date. This acquisition gives us regulatory consulting, outsourcing and operations capabilities for our clients in the life sciences industry. Goodwill of $110.0 million, representing the excess of the preliminary estimated purchase price over the net assets acquired, has been allocated to our India reporting unit.

Earn-out consideration

The terms of the acquisition agreements for certain business acquisitions provide for payment of additional earn-out consideration if certain future events or conditions are met. These earn-outs were recorded as liabilities based on their fair values as of the acquisition dates. We evaluate the fair value of earn-out consideration for the respective acquisitions for changes at each reporting period and record the corresponding changes in “Other operating (income) expense, net” in the Consolidated Statements of Income. We recorded a decrease in the fair value of earn-out consideration for the three months ended June 30, 2013 and June 30, 2014 of $2.3 million and $0.6 million respectively, and for the six months ended June 30, 2013 and June 30, 2014 of $2.3 million and $2.2 million respectively.

Critical Accounting Policies and Estimates

For a description of our critical accounting policies, see Note 2—“Summary of significant accounting policies” under Item 1—“Financial Statements” above and Part II, Item 7—“Management’s Discussion and Analysis of Financial Condition and Results of Operations —Critical Accounting Policies and Estimates” in our Annual Report on Form 10-K for the year ended December 31, 2013.

Results of Operations

The following table sets forth certain data from our consolidated statements of income for the three months and six months ended June 30, 2013 and 2014.


													Percentage Change Increase/(Decrease)
													Three			Six
													months			months
													ended			ended
													June 30,			June 30,
	Three months ended June 30,						Six months ended June 30,						2014 vs.			2014 vs.
	2013			2014			2013			2014			2013			2013
	(dollars in millions)						(dollars in millions)
Net revenues—GE*	$	121.6		$	119.8		$	238.7		$	230.0			(1.5	)%		(3.6	)%
Net revenues—Global Clients*		413.2			441.8			800.0			859.8			6.9	%		7.5	%

Total net revenues		534.8			561.6			1,038.7			1,089.8			5.0	%		4.9	%

Cost of revenue		332.7			340.1			644.4			664.4			2.2	%		3.1	%

Gross profit		202.1			221.5			394.2			425.4			9.6	%		7.9	%

Gross profit margin		37.8	%		39.4	%		38.0	%		39.0	%

Operating expenses:
Selling, general and administrative expenses		118.4			142.7			231.6			265.2			20.5	%		14.5	%
Amortization of acquired intangible assets		6.2			6.6			11.7			12.6			6.9	%		7.6	%
Other operating (income) expense, net		(0.5	)		(0.9	)		(1.1	)		(2.8	)		83.1	%		152.9	%

Income from operations		78.0			73.1			151.9			150.3			(6.3	)%		(1.1	)%
Income from operations as a percentage of total net revenues		14.6	%		13.0	%		14.6	%		13.8	%
Foreign exchange (gains) losses, net		(17.2	)		3.8			(13.8	)		7.4			(122.3	)%		(153.8	)%
Other income (expense), net		(10.5	)		(6.5	)		(15.7	)		(13.0	)		(38.3	)%		(16.7	)%

Income before equity method investment activity, net and income tax expense		84.6			62.7			150.1			129.8			(25.9	)%		(13.5	)%
Equity method investment activity, net		(0.1	)		(0.0	)		(0.1	)		(0.1	)		(46.0	)%		(49.5	)%

Income before income tax expense		84.7			62.8			150.2			129.9			(25.9	)%		(13.5	)%
Income tax expense		19.2			13.9			36.5			30.1			(28.0	)%		(17.4	)%

Net income		65.5			48.9			113.7			99.8			(25.3	)%		(12.3	)%
Net income attributable to noncontrolling interest		1.6			(0.1	)		3.1			0.2			(105.3	)%		(95.0	)%

Net income attributable to Genpact Limited shareholders	$	63.9		$	49.0		$	110.6		$	99.6			(23.3	)%		(10.0	)%

Net income attributable to Genpact Limited shareholders as a percentage of total net revenues		11.9	%		8.7	%		10.6	%		9.1	%

*	Net revenues from certain businesses in which GE ceased to be a 20% shareholder are classified as a part of GE net revenues up to the time of their divestiture by GE and as a part of Global Client net revenues post-divestiture.

“Net revenues—Global Clients” for the six months and three months ended June 30, 2013 disclosed in the foregoing table includes net revenues earned from a client who is an affiliate of a significant shareholder of the Company. “Net revenues—Global Clients” for the six months and three months ended June 30, 2014 disclosed in the foregoing table includes net revenues earned from a client who is a significant shareholder of the Company as described in note 21 in Part I—Financial Statements.

Three Months Ended June 30, 2014 Compared to the Three Months Ended June 30, 2013

Net revenues. Our net revenues were $561.6 million in the second quarter of 2014, up $26.8 million, or 5.0%, from $534.8 million in the second quarter of 2013. Foreign exchange had an adverse impact on our net revenues in the second quarter of 2014. Adjusted for the same, our net revenues grew 5.6% compared to the second quarter of 2013. The growth in net revenues was primarily due to an increase in business process outsourcing, or BPO, services delivered to our Global Clients, an increase in information technology, or IT, services delivered to our Global Clients and GE, and to the acquisition of Pharmalink, which we refer to as our “regulatory affairs acquisition.” Our annualized net revenue per employee for the second quarter of 2014 was $35,600, compared to $36,700 in the second quarter of 2013. The moderate decline in revenue per employee is due in part to an increase in the personnel required for large, transformational deals, particularly during the extended transition periods associated with these complex engagements. Our average headcount increased to approximately 63,800 in the second quarter of 2014 from approximately 58,300 in the second quarter of 2013.


	Three months ended June 30,				Percentage change Increase/(Decrease)
	2013		2014		2014 vs. 2013
	(dollars in millions)
BPO Services	$	401.8	$	424.8		5.7	%
IT Services		133.0		136.8		2.9

Total net revenues	$	534.8	$	561.6		5.0	%

Net revenues from BPO services for the second quarter of 2014 were $424.8 million, up $23.0 million, or 5.7%, from $401.8 million in the second quarter of 2013. This increase was primarily due to an increase in revenues from our Global Clients, particularly for finance and accounting services and consulting services, and to the acquisition of Pharmalink in the second quarter of 2014. Net revenues from IT services were $136.8 million in the second quarter of 2014, up $3.8 million, or 2.9%, from $133.0 million in the second quarter of 2013 as a result of an increase in revenues from our Global Clients and GE.

Net revenues from BPO services as a percentage of total net revenues increased to 75.6% in the second quarter of 2014 from 75.1% in the second quarter of 2013 with a corresponding decline in the percentage of total net revenues attributable to IT services.


	Three months ended June 30,				Percentage change Increase/(Decrease)
	2013		2014		2014 vs. 2013
	(dollars in millions)
GE	$	121.6	$	119.8		(1.5	)%
Global Clients		413.2		441.8		6.9

Total net revenues	$	534.8	$	561.6		5.0	%

Net revenues from Global Clients in the second quarter of 2014 were $441.8 million, up $28.6 million, or 6.9%, from $413.2 million in the second quarter of 2013. This increase was primarily a result of growth in the consumer packaged goods, life sciences, insurance and capital markets verticals. BPO and IT services revenues from Global Clients grew by 8.8% and 1.6%, respectively.

Net revenues from GE were $119.8 million in the second quarter of 2014, down $1.8 million, or 1.5%, from the second quarter of 2013 as a result of a 4.1% decrease in BPO services revenues from, and divestitures by, GE. This decrease was partially offset by an increase in IT services revenues from GE, which grew by 8.3% in the second quarter of 2014 compared to the second quarter of 2013. Net revenues from certain businesses in which GE ceased to be a 20% shareholder are classified as a part of GE net revenues up to the time of their divestiture by GE and as a part of Global Client net revenues post-divestiture. Net revenues from GE in the second quarter of 2014, after excluding net revenues from such dispositions by GE, decreased by 1.2% from the second quarter of 2013. Net revenues from GE as a percentage of our total net revenues declined from 22.7% in the second quarter of 2013 to 21.3% in the second quarter of 2014.

Net revenues by geographic region based on the location of our service delivery centers are as follows:


					Percentage change
	Three months ended June 30,				Increase/(Decrease)
	2013		2014		2014 vs. 2013
	(dollars in millions)
India	$	350.8	$	370.0		5.5	%
Americas		75.0		75.1		0.1
Asia, other than India		54.9		56.4		2.6
Europe		54.0		60.2		11.3

Total net revenues	$	534.8	$	561.6		5.0	%

Net revenues grew in all of our geographic regions in the second quarter of 2014. Net revenues from service delivery centers located in Europe contributed $60.2 million to total net revenues in the second quarter of 2014, up 11.3% from the second quarter of 2013. Approximately $1.2 million of this increase was attributable to the regulatory affairs acquisition in the second quarter of 2014. Net revenues attributable to India-based service delivery centers were $370.0 million in the second quarter of 2014, up 5.5% from the second quarter of 2013. A portion of net revenues attributable to India-based service delivery centers includes net revenues for services performed from service delivery centers outside India that are managed by India-based service delivery leaders or at clients’ premises outside India by personnel normally based in India. Net revenues from service delivery centers located in Asia, other than India, contributed $56.4 million to total net revenues in the second quarter of 2014, up 2.6% from the second quarter of 2013. The balance of net revenues, which is attributable to service delivery centers located in the Americas, was $75.1 million in the second quarter of 2014, marginally up 0.1% from the second quarter of 2013.

Cost of revenue and gross profit. The following table sets forth the components of our cost of revenue and the resulting gross profit:


	Three Months Ended June 30,				As a Percentage of Total Net Revenues
	2013		2014		2013			2014
	(dollars in millions)
Personnel expenses	$	229.1	$	230.0		42.8	%		40.9	%
Operational expenses		91.2		99.1		17.1			17.6
Depreciation and amortization		12.4		11.1		2.3			2.0

Cost of revenue	$	332.7	$	340.1		62.2	%		60.6	%

Gross Profit	$	202.1	$	221.5		37.8	%		39.4	%

Cost of revenue as a percentage of total net revenues decreased from 62.2% in the second quarter of 2013 to 60.6% in the second quarter of 2014 primarily due to higher operational efficiencies and the effects of foreign exchange volatility, which reflect the net impact of gains and losses on our foreign currency hedges and the U.S. dollar-translation, for reporting purposes, of the income statements of certain subsidiaries whose functional currencies are other than the U.S. dollar. The impact of these factors was partially offset by wage inflation.

Cost of revenue for the second quarter of 2014 was $340.1 million, up $7.4 million, or 2.2%, from the second quarter of 2013. Of this increase, approximately $2.7 million, or 35.6%, is attributable to the regulatory affairs acquisition in the second quarter of 2014. Wage inflation, an increase in personnel expenses due to an increase in our operational headcount and increased use of subcontractors for service delivery also contributed to higher cost of revenue in the second quarter of 2014 compared to the second quarter of 2013.

Personnel expenses. Personnel expenses as a percentage of total net revenues decreased from 42.8% in the second quarter of 2013 to 40.9% in the second quarter of 2014, primarily as a result of improved operational efficiencies, including effective deployment and utilization of supervisory personnel and the increased use of subcontractors for service delivery. Personnel expenses for the second quarter of 2014 were $230.0 million, up $0.9 million, or 0.4%, from $229.1 million in the second quarter of 2013. The regulatory affairs acquisition in the second quarter of 2014 resulted in approximately $1.5 million of additional personnel expenses.

Additionally, wage inflation and an approximately 3,900-person, or 7.6%, increase in our operational headcount (excluding the regulatory affairs acquisition) contributed to higher personnel expenses. These increases were partially offset by the impact of the operational efficiencies described above, the increased use of subcontractors, the effects of foreign exchange volatility, and a $1.3 million reduction in stock-based compensation in the second quarter of 2014 compared to the second quarter for 2013.

Operational expenses. Operational expenses as a percentage of total net revenues increased from 17.1% in the second quarter of 2013 to 17.6% in the second quarter of 2014, primarily due to the increased use of subcontractors for service delivery. Operational expenses for the second quarter of 2014 were $99.1 million, up $7.9 million, or 8.6%, from the second quarter of 2013. Of this increase, approximately $1.1 million, or 13.8%, is attributable to the regulatory affairs acquisition in the second quarter of 2014. Subcontractor expenses increased by approximately $8.9 million in the second quarter of 2014 compared to the second quarter of 2013. These increases were partially offset by a reduction in infrastructure and communication expenses resulting from the more effective use of our facilities and collaborative tools in the second quarter of 2014 compared to the second quarter of 2013 and by the effects of foreign exchange volatility.

Depreciation and amortization expenses. Depreciation and amortization expenses as a component of cost of revenue for the second quarter of 2014 were $11.1 million, down $1.3 million, or 10.6%, from the second quarter of 2013. Depreciation and amortization expenses as a percentage of total net revenues decreased from 2.3% in the second quarter of 2013 to 2.0% in the second quarter of 2014. These decreases were primarily due to an increase in fully depreciated assets since the end of the second quarter of 2013 at our service delivery centers located in India, the Philippines and the Americas and were partially offset by depreciation and amortization expenses resulting from the expansion of certain existing facilities, from the addition of new service delivery centers in India and from our regulatory affairs acquisition.

As a result of the foregoing, our gross profit increased by $19.4 million, or 9.6%, and our gross margin increased from 37.8% in the second quarter of 2013 to 39.4% in the second quarter of 2014.

Selling, general and administrative expenses. The following table sets forth the components of our selling, general and administrative, or SG&A, expenses:


	Three Months Ended June 30,				As a Percentage of Total Net Revenues
	2013		2014		2013			2014
	(dollars in millions)
Personnel expenses	$	85.7	$	101.2		16.0	%		18.0	%
Operational expenses		30.6		39.5		5.7			7.0
Depreciation and amortization		2.1		2.1		0.4			0.4

Selling, general and administrative expenses	$	118.4	$	142.7		22.1	%		25.4	%

SG&A expenses as a percentage of total net revenue increased from 22.1% in the second quarter of 2013 to 25.4% in the second quarter of 2014. SG&A expenses in the second quarter of 2014 were $142.7 million, up $24.3 million, or 20.5%, from the second quarter of 2013. SG&A expenses increased as a result of our investments in client-facing teams and subject matter experts through the hiring of seasoned, high-cost personnel in targeted markets – such as the United States and Europe – and industry verticals – namely, banking and financial services, insurance, consumer packaged goods and life sciences and the effects of wage inflation. These investments in sales and marketing have been made in order to drive our future growth. As a result, our sales and marketing expenses as a percentage of revenue were approximately 6.6% in the second quarter of 2014, up from approximately 4.3% in the second quarter of 2013. Of the total increase in SG&A expenses, $1.3 million was attributable to the regulatory affairs acquisition in the second quarter of 2014. Additionally, acquisition-related expenses, travel costs and fees for professional services, including for controlling costs and improving productivity, contributed to higher SG&A expenses. These increases were partially offset by an expense of $1.1 million in the second quarter of 2013 resulting from the amendment of our credit facility and by the effects of foreign exchange volatility.

Personnel expenses. Personnel expenses as a percentage of total net revenues in the second quarter of 2014 were 18.0%, up from 16.0% in the second quarter of 2013. Personnel expenses as a component of SG&A expenses were $101.2 million in the second quarter of 2014, up $15.5 million, or 18.1%, from the second quarter of 2013. Investments in client-facing teams and wage inflation resulted in an approximately 33.9% increase in sales team personnel expenses. The regulatory affairs acquisition in the second quarter of 2014 also contributed an additional $0.7 million to personnel expenses. Additionally, wage inflation and an increase in our support headcount contributed to higher personnel costs. The increase in personnel expenses was partially offset by a $1.9 million decrease in stock-based compensation cost in the second quarter of 2014 compared to the second quarter of 2013 and by the effects of foreign exchange volatility.

Operational expenses. Operational expenses as a percentage of total net revenues increased from 5.7% in the second quarter of 2013 to 7.0% in the second quarter of 2014. This increase was primarily attributable to higher marketing expenditures, increased sales-related travel and fees for professional services. Operational expenses as a component of SG&A expenses increased by $8.9 million, or 29.0%, in the second quarter of 2014 compared to the second quarter of 2013. Of this increase, approximately $0.6 million, or 6.9%, is attributable to the regulatory affairs acquisition in the second quarter of 2014. We also incurred acquisition-related expenses in the second quarter of 2014. The increase in operational expenses was partially offset by an expense of $1.1 million in the second quarter of 2013 resulting from the amendment of our credit facility and by the effects of foreign exchange volatility in the second quarter of 2014.

Depreciation and amortization. Depreciation and amortization expenses as a percentage of total net revenues were unchanged at 0.4% in the second quarter of 2014. There was an increase in fully depreciated assets since the end of the second quarter of 2013 at our service delivery centers located in India, the Philippines and the Americas, resulting in lower depreciation and amortization expenses, which was offset by depreciation and amortization expenses resulting from the expansion of certain existing facilities, from the addition of new service delivery centers in India, and from the regulatory affairs acquisition in the second quarter of 2014.

Amortization of acquired intangibles. Non-cash charges on account of the amortization of acquired intangibles were $6.6 million in the second quarter of 2014, up from $6.2 million in the second quarter of 2013. The acquisitions we completed during 2013 and 2014 resulted in additional amortization expenses of $0.9 million. This increase was partially offset by a decline of $0.3 million in the amortization expense of intangibles arising out of our reorganization in 2004, when we began operating as an independent company. In each case, the amortization was consistent with the applicable estimated useful life of the acquired intangible asset.

Other operating (income) expense, net. Other operating income, net of expenses, for the second quarter of 2014 was $0.9 million, up from $0.5 million in the second quarter of 2013. In the second quarter of 2013, we recorded a $2.4 million non-recurring provision for impairment against certain capital assets in India that were no longer strategic to our growth. Additionally, there was a gain of $0.6 million in the second quarter of 2014 due to changes in the fair value of earn-out consideration relating to certain acquisitions compared to a gain of $2.3 million in the second quarter of 2013.

Income from operations. As a result of the foregoing factors, income from operations decreased by $4.9 million to $73.1 million in the second quarter of 2014 from $78.0 million in the second quarter of 2013. As a percentage of total net revenues, income from operations decreased from 14.6% in the second quarter of 2013 to 13.0% in the second quarter of 2014.

Foreign exchange (gains) losses, net. We recorded a net foreign exchange loss of $3.8 million in the second quarter of 2014, compared to a net foreign exchange gain of $17.2 million in the second quarter of 2013, primarily due to the re-measurement of our non-functional currency assets and liabilities and related foreign exchange contracts resulting from the appreciation of the Indian rupee and Philippine peso against the U.S. dollar and the depreciation of the euro against the U.S. dollar, each in the second quarter of 2014, and depreciation of the India rupee and Philippine Peso against the U.S. dollar in the second quarter of 2013.

Other income (expense), net. The following table sets forth the components of other income (expense), net:


	Three months ended June 30,						Percentage change Increase/(Decrease)
	2013			2014			2013 vs. 2014
	(dollars in millions)
Interest income	$	4.5		$	0.6			(86.0	)%
Interest expense		(12.8	)		(7.6	)		(40.2	)
Provision (created) reversed for loss on divestures		(2.9	)		—			(100.0	)
Other income		0.7			0.5			(27.1	)

Other income (expense), net	$	(10.5	)	$	(6.5	)		(38.3	)%

Other income (expense), net as a percentage of total net revenues		(2.0	)%		(1.2	)%

Our net other expenses decreased by $4.0 million in the second quarter of 2014 compared to the second quarter of 2013, primarily due to a decrease in net interest expense in the second quarter of 2014 and a provision created for losses on divestitures in the second quarter of 2013. In the second quarter of 2013, we reserved $0.6 million and $2.3 million for the divestitures of Clearbizz B.V. and Gantthead.com, Inc., respectively. Additionally, in the second quarter of 2013, we amended our August 2012 credit facility, resulting in an expense of $3.1 million. Further, interest expense decreased $1.3 million as a result of a lower interest rate on our credit facility in the second quarter of 2014 compared to the second quarter of 2013. As a result, the weighted average rate of interest on our debt decreased from 4.1% in the second quarter of 2013 to 3.4% in the second quarter of 2014. Our interest income also decreased by $3.9 million in the second quarter of 2014 primarily as a result of lower balances in accounts in India due to a repatriation of cash from India to the United States.

Income before equity method investment activity, net and income tax expense. As a result of the foregoing factors, income before equity method investment activity, net and income tax expense decreased by $21.9 million in the second quarter of 2014 compared to the second quarter of 2013. As a percentage of net revenues, income before equity method investment activity, net and income tax expense declined from 15.8% in the second quarter of 2013 to 11.2% the second quarter of 2014.

Equity-method investment activity, net. Equity-method investment activity, net represents our share of gain or loss from our non-consolidated affiliate, NIIT Uniqua, a joint venture with NIIT Limited, one of the largest training institutes in Asia.

Income before income tax expense. As a result of the foregoing factors, income before income tax expense decreased by $21.9 million. As a percentage of net revenues, income before income tax expense decreased from 15.8% in the second quarter of 2013 to 11.2% in the second quarter of 2014.

Income tax expense. Our income tax expense decreased from $19.2 million in the second quarter of 2013 to $13.9 million in the second quarter of 2014, representing an effective tax rate, or ETR, of 22.0% in the second quarter of 2014, down from 23.1% in the second quarter of 2013. The improvement in our ETR was primarily a consequence of the continued growth of our operations in lower tax and tax-exempt locations, primarily in India, and certain tax benefits recognized in the second quarter of 2014 as a result of the lapse of a statute of limitations.

Net income. As a result of the foregoing factors, net income decreased by $16.6 million from $65.5 million in the second quarter of 2013 to $48.9 million in the second quarter of 2014. As a percentage of net revenues, our net income decreased from 12.2% of net revenues in the second quarter of 2013 to 8.7% of net revenues in the second quarter of 2014.

Net income attributable to noncontrolling interest. Noncontrolling interest primarily refers to the profit or loss associated with our noncontrolling partners’ interest in the operations of Genpact Netherlands B.V. and the noncontrolling shareholders’ interest in the operations of Hello Communications (Shanghai) Co., Ltd. Net income attributable to noncontrolling interest decreased from $1.6 million in the second quarter of 2013 to a loss of $0.1 million in the second quarter of 2014. This decrease was primarily attributable to our purchase of certain partners’ interests in Genpact Netherlands B.V., reducing the noncontrolling partners’ total interest in the operation of Genpact Netherlands B.V., and to our divestiture of Hello Communications (Shanghai) Co. Ltd. in the second quarter of 2013.

Net income attributable to Genpact Limited common shareholders. As a result of the foregoing factors, net income attributable to our common shareholders decreased by $14.9 million from $63.9 million in the second quarter of 2013 to $49.0 million in the second quarter of 2014. As a percentage of net revenues, net income attributable to Genpact Limited common shareholders decreased from 11.9% in the second quarter of 2013 to 8.7% in the second quarter of 2014.

Six Months Ended June 30, 2014 Compared to the Six Months Ended June 30, 2013

Net revenues. Our net revenues were $1,089.8 million in the first half of 2014, up $51.1 million, or 4.9%, from $1,038.7 million in the first half of 2013. Foreign exchange had an adverse impact on our net revenues in the first half of 2014. Adjusted for the same, our net revenues grew 6.1% compared to the first half of 2013. The growth in our net revenues was primarily due to an increase in BPO services delivered to our Global Clients, an increase in IT services delivered to our Global Clients and GE, and to our regulatory affairs acquisition in the second quarter of 2014. Our annualized net revenue per employee for the first half of 2014 was $34,900, compared to $35,600 in the first half of 2013. The moderate decline in revenue per employee is due in part to an increase in personnel required for large transformational deals, particularly during the extended transition periods associated with these complex engagements. Our average headcount increased to approximately 63,300 in the first half of 2014 from approximately 58,600 in the first half of 2013.


	Six months ended June 30,				Percentage change Increase/(Decrease)
	2013		2014		2014 vs. 2013
	(dollars in millions)
BPO Services	$	785.8	$	822.8		4.7	%
IT Services		252.9		267.0		5.6

Total net revenues	$	1,038.7	$	1,089.8		4.9	%

Net revenues from BPO services in the first half of 2014 were $822.8 million, up $37.0 million, or 4.7%, from $785.8 million in the first half of 2013, due to an increase in revenues from our Global Clients, particularly for consulting services and finance and accounting services, and to the regulatory affairs acquisition in the second quarter of 2014. Net revenues from IT services were $267.0 million in the first half of 2014, up $14.1 million, or 5.6%, from $252.9 million in the first half of 2013 as a result of an increase in revenues from our Global Clients and GE.

Net revenues from IT services as a percentage of total net revenues increased to 24.5% in the first half of 2014, up from 24.3% in the first half of 2013 with a corresponding decline in the percentage of total net revenues attributable to BPO services.


	Six months ended June 30,				Percentage change Increase/(Decrease)
	2013		2014		2014 vs. 2013
	(dollars in millions)
GE	$	238.7	$	230.0		(3.6	)%
Global Clients		800.0		859.8		7.5

Total net revenues	$	1,038.7	$	1,089.8		4.9	%

Net revenues from Global Clients in the first half of 2014 were $859.8 million, up $59.8 million, or 7.5%, from $800.0 million in the first half of 2013. This increase was primarily a result of growth in the consumer packaged goods, life sciences, insurance, capital markets and infrastructure, manufacturing and services verticals. As a percentage of total net revenues, net revenues from Global Clients increased from 77.0% in the first half of 2013 to 78.9% in the first half of 2014. BPO and IT services revenues from Global clients grew by 7.9% and 6.2%, respectively.

Net revenues from GE were $230.0 million in the first half of 2014, down $8.7 million, or 3.6%, from the first half of 2013 as a result of a 5.4% decrease in BPO services revenues from, and divestitures by, GE. This decrease was partially offset by an increase in IT services revenues from GE, which grew by 3.0% in the first half of 2014 compared to the first half of 2013. Net revenues from certain businesses in which GE ceased to be a 20% shareholder are classified as a part of GE net revenues up to the time of their divestiture by GE and as a part of Global Client net revenues post-divestiture. Net revenues from GE in the second quarter of 2014, after excluding net revenues from such dispositions by GE, decreased by 2.1% from the first half of 2013. Net revenues from GE as a percentage of our total net revenues declined from 23.0% in the first half of 2013 to 21.1% in the first half of 2014.

Net revenues by geographic region based on the location of our service delivery centers are as follows:


	Six months ended June 30,				Percentage change Increase/(Decrease)
	2013		2014		2014 vs. 2013
	(dollars in millions)
India	$	681.2	$	712.5		4.6	%
Americas		141.0		148.4		5.3
Asia, other than India		111.0		114.7		3.3
Europe		105.5		114.2		8.3

Total net revenues	$	1,038.7	$	1,089.8		4.9	%

Net revenues grew in all of our geographic regions in the first half of 2014. Net revenues from service delivery centers located in Europe contributed $114.2 million to total net revenues in the first half of 2014, up 8.3% from the first half of 2013. Approximately $1.2 million of this increase was attributable to the regulatory affairs acquisition in the second quarter of 2014. Total net revenues from India-based service delivery centers were $712.5 million in the first half of 2014, up 4.6% from the first half of 2013. A portion of net revenues attributable to India-based service delivery centers includes net revenues for services performed from service delivery centers outside India that are managed by India-based service delivery leaders or at clients’ premises outside India by personnel normally based in India. Service delivery centers located in the Americas contributed $148.4 million to total net revenues in the first half of 2014, up 5.3% from the first half of 2013. Net revenues from service delivery centers located in Asia, other than India, contributed $114.7 million to total net revenues in the first half of 2014, up 3.3% from the first half of 2013.

Cost of revenue and gross profit. The following table sets forth the components of our cost of revenue and the resulting gross profit:


	Six Months Ended June 30,				As a Percentage of Total Net Revenues
	2013		2014		2013			2014
	(dollars in millions)
Personnel expenses	$	447.5	$	457.0		43.1	%		41.9	%
Operational expenses		172.7		185.5		16.6			17.0
Depreciation and amortization		24.2		21.9		2.3			2.0

Cost of revenue	$	644.4	$	664.4		62.0	%		61.0	%

Gross Profit		394.2		425.4		38.0	%		39.0	%

Cost of revenue as a percentage of total net revenues decreased from 62.0% in the first half of 2013 to 61.0% in the first half of 2014 primarily due to improved operational efficiencies and the effects of foreign exchange volatility. The impact of these factors was partially offset by wage inflation.

Cost of revenue for the first half of 2014 was $664.4 million, up $20.0 million, or 3.1%, from the first half of 2013. Of this increase, approximately $8.7 million, or 43.2%, is attributable to acquisitions completed in 2013 and 2014. Wage inflation, an increase in personnel expenses due to an increase in our operational headcount and increased use of subcontractors for service delivery also contributed to higher cost of revenue in the first half of 2014 compared to the first half of 2013. These increases were partially offset by lower stock-based compensation costs, the effects of foreign exchange volatility, and improved operational efficiencies in the first half of 2014 compared to the first half of 2013.

Personnel expenses. Personnel expenses as a percentage of total net revenues decreased from 43.1% in the first half of 2013 to 41.9% in the first half of 2014, primarily due to improved operational efficiencies, including more effective deployment and utilization of supervisory personnel, and the increased use of subcontractors for service delivery. Personnel expenses for the first half of 2014 were $457.0 million, up $9.5 million, or 2.1%, from $447.5 million in the first half of 2013. Approximately $6.3 million of this increase is attributable to acquisitions completed in 2013 and 2014. The impact of wage inflation and an approximately 3,300-person, or 6.5%, increase in our operational headcount in the first half of 2014 compared to same period in 2013 (excluding acquisitions completed in 2013 and 2014) also contributed to higher personnel expenses. These increases were partially offset by the impact of the operational efficiencies described above, the increased use of subcontractors, the effects of foreign exchange volatility, and a $2.1 million decrease in stock-based compensation expenses in the first half of 2014 compared to the first half for 2013.

Operational expenses. Operational expenses for the first half of 2014 were $185.5 million, up $12.8 million, or 7.4%, from the first half of 2013. Operational expenses as a percentage of total net revenues increased from 16.6% in the first half of 2013 to 17.0% in the first half of 2014. Approximately $2.3 million, or 17.6%, of the increase is attributable to acquisitions completed during 2013 and 2014. Subcontractor costs and business travel expenses increased by approximately $12.3 million and $2.4 million, respectively, in the first half of 2014 compared to the first half of 2013. These increases were partially offset by the effects of foreign exchange volatility and a reduction in infrastructure and communication expenses resulting from the more effective use of our facilities and collaborative tools in the first half of 2014 compared to the first half of 2013.

Depreciation and amortization expenses. Depreciation and amortization expenses as a component of cost of revenue in the first half of 2014 were $21.9 million, down $2.3 million, or 9.6%, from the first half of 2013. Depreciation and amortization expenses as a percentage of total net revenues decreased from 2.3% in the first half of 2013 to 2.0% in the first half of 2014. These decreases were

primarily due to an increase in fully depreciated assets since the end of the first half of 2013 at our service delivery centers located in India, the Philippines and the Americas and were partially offset by depreciation and amortization expenses resulting from the expansion of certain existing facilities, from the addition of new service delivery centers in India and from acquisitions completed in 2013 and 2014.

As a result of the foregoing, our gross profit increased by $31.2 million, or 7.9%, and our gross margin increased from 38.0% in the first half of 2013 to 39.0% in the first half of 2014.

Selling, general and administrative expenses. The following table sets forth the components of our selling, general and administrative, or SG&A, expenses:


	Six Months Ended June 30,				As a Percentage of Total Net Revenues
	2013		2014		2013			2014
	(dollars in millions)
Personnel expenses	$	167.8	$	190.7		16.2	%		17.5	%
Operational expenses		59.5		70.4		5.7			6.5
Depreciation and amortization		4.3		4.1		0.4			0.4

Selling, general and administrative expenses	$	231.6	$	265.2		22.3	%		24.3	%

SG&A expenses as a percentage of total net revenue increased from 22.3% in the first half of 2013 to 24.3% in the first half of 2014. SG&A expenses for the first half of 2014 were $265.2 million, up $33.6 million, or 14.5%, from the first half of 2013. Investments in client-facing teams and subject matter experts through the hiring of seasoned, high-cost personnel in targeted markets – such as the United States and Europe – and industry verticals – namely banking and financial services, insurance, consumer goods and life sciences – along with the impact of wage inflation resulted in higher SG&A expenses. These investments in sales and marketing have been made in order to drive our future growth. Of the total increase in SG&A expenses, approximately $2.7 million, or 7.9%, is attributable to the acquisitions completed in 2013 and 2014. Additionally, higher expenditures on marketing, acquisition-related expenses, fees for professional services, including for controlling costs and improving productivity, and travel also contributed to higher SG&A expenses in the first half of 2014 compared to the first half of 2013. These increases were partially offset by a lower reserve for doubtful debts created in the first half of 2014, lower stock-based compensation costs in the first half of 2014 compared to the first half of 2013 and by the effects of foreign exchange volatility.

Personnel expenses. Personnel expenses as a percentage of total net revenues in the first half of 2014 were 17.5%, up from 16.2% in the first half of 2013. Investments in client-facing teams and wage inflation resulted in a 23.5% increase in sales team personnel expenses. Personnel expenses as a component of SG&A expenses were $190.7 million in the first half of 2014, up $22.9 million, or 13.6%, from the first half of 2013. Approximately $1.3 million of this increase is due to acquisitions completed in 2013 and 2014. Wage inflation and an increase in our support headcount also resulted in higher personnel costs in the first half of 2014 compared to the first half of 2013. This increase was partially offset by a $2.7 million decrease in stock-based compensation costs in the first half of 2014 compared to the first half of 2013 and by the effects of foreign exchange volatility.

Operational expenses. Operational expenses as a component of SG&A expenses increased by $10.8 million, or 18.2%, in the first half of 2014 compared to the first half of 2013. Approximately $0.8 million of this increase is attributable to acquisitions completed in 2013 and 2014. Higher marketing, sales-related travel and professional services expenses also resulted in higher operational expenses in the first half of 2014 compared to the first half of 2013. We also incurred acquisition-related expenses of $2.0 million in the first half of 2014 for our regulatory affairs acquisition. As a result, our operational expenses increased as a percentage of total net revenues. This increase was partially offset by a $3.4 million decline in the reserve for doubtful receivables in the first half of 2014, an expense of $1.1 million relating to the amendment of our credit facility in 2013 and the effects of foreign exchange volatility. As a result, our operational expenses as a percentage of total net revenues increased from 5.7% in the first half of 2013 to 6.5% in the first half of 2014.

Depreciation and amortization. Depreciation and amortization expenses as a percentage of total net revenues were unchanged at 0.4%. There was an increase in fully depreciated assets since the end of the first half of 2013 at our service delivery centers located in India, the Philippines and the Americas, resulting in lower depreciation and amortization expenses, which was offset by depreciation and amortization expenses resulting from the expansion of certain existing facilities in India, from the addition of new service delivery centers and from acquisitions completed in 2013 and 2014.

Amortization of acquired intangibles. Non-cash charges on account of the amortization of acquired intangibles were $12.6 million in the first half of 2014, up from $11.7 million in the first half of 2013. The acquisitions we completed during 2013 and 2014 resulted in additional amortization expenses of $1.4 million in the first half of 2014. This increase was partially offset by a $0.6 million decline in the amortization expense of intangibles arising out of our reorganization in 2004, when we began operating as an independent company. In each case, the amortization was consistent with the applicable estimated useful life of the acquired intangible asset.

Other operating (income) expense, net. Other operating income, net of expenses, for the first half of 2014 was $2.8 million, up from $1.1 million in the first half of 2013. In the second quarter of 2013, we recorded a $2.4 million non-recurring provision for impairment against certain capital assets in India that were no longer strategic to our growth. This was offset by a reduction in shared services income, which decreased from $1.2 million in the first half of 2013 to $0.6 million in the first half of 2014.

Income from operations. As a result of the foregoing factors, income from operations decreased by $1.6 million to $150.3 million in the first half of 2014 from $151.9 million in the first half of 2013. As a percentage of total net revenues, income from operations decreased from 14.6% in the first half of 2013 to 13.8% in the first half of 2014.

Foreign exchange (gains) losses, net. We recorded a net foreign exchange loss of $7.4 million in the first half of 2014, compared to a net foreign exchange gain of $13.8 million in the first half of 2013, primarily due to the re-measurement of our non-functional currency assets and liabilities and related foreign exchange contracts resulting from the appreciation of the Indian rupee against the U.S. dollar in the first half of 2014 compared to the depreciation of the Indian rupee against the U.S. dollar in the first half of 2013.

Other income (expense), net. The following table sets forth the components of other income (expense), net:


	Six months ended June 30,						Percentage change Increase/(Decrease)
	2013			2014			2013 vs. 2014
	(dollars in millions)
Interest income	$	9.8		$	2.0			(79.7	)%
Interest expense		(22.7	)		(15.4	)		(32.2	)
Provision (created) reversed for loss on divestures		(3.7	)		—			(100.0	)
Other income		1.0			0.4			(60.6	)

Other income (expense), net	$	(15.7	)	$	(13.0	)		(16.7	)%

Other income (expense), net as a percentage of total net revenues		(1.5	)%		(1.2	)%

Our net other expenses decreased by $2.6 million in the first half of 2014 compared to the first half of 2013, primarily due to a provision for loss on divestitures created in the first half of 2013 which was partially offset by an increase in our net interest expense in the first half of 2014. In the first half of 2013, we reserved amounts of $1.3 million and $2.3 million for losses on the divestitures of Clearbizz B.V. and Gantthead.com, Inc., respectively. Our net interest expense increased by $0.5 million as the result of a $7.3 million decrease in interest expense and a $7.8 million decrease in interest income in the first half of 2014 compared to the first half of 2013. The decrease in interest expense was the result of an expense of $3.1 million in the first half of 2013 relating to the amendment to our credit facility and a lower interest expense of $3.1 million in the first half of 2014 due to a lower interest rate on the amended facility. As a result, the weighted average rate of interest on our debt decreased from 4.1% in the first half of 2013 to 3.4% in the first half of 2014. Our interest income also decreased by $7.8 million in the first half of 2014 primarily as a result of lower balances in accounts in India during the first half of 2014 compared to the first half of 2013 due to a repatriation of cash from India to the United States.

Income before equity method investment, activity, net and income tax expense. As a result of the foregoing factors, income before equity method investment activity, net and income tax expense decreased by $20.3 million in the first half of 2014 compared to the first half of 2013. As a percentage of net revenues, income before equity method investment activity, net and income tax expense decreased from 14.5% in the first half of 2013 to 11.9% in the first half of 2014.

Equity-method investment activity, net. Equity-method investment activity, net represents our share of gain or loss from our non-consolidated affiliates, NGEN Media Services Private Limited, or NGEN, a joint venture with NDTV Networks Plc., and NIIT

Uniqua, a joint venture with NIIT Limited, one of the largest training institutes in Asia. In March 2013, we acquired the remaining equity interest in NGEN.

Income before income tax expense. As a result of the foregoing factors, our income before income tax expense decreased by $20.3 million. As a percentage of net revenues, income before income tax expense decreased from 14.5% of net revenues in the first half of 2013 to 11.9% of net revenues in the first half of 2014.

Income tax expense. Our income tax expense decreased from $36.5 million in the first half of 2013 to $30.1 million in the first half of 2014, representing an ETR of 23.2% in the first half of 2014, down from 24.8% in the first half of 2013. The improvement in our ETR was primarily a consequence of the continued growth of our operations in lower tax and tax-exempt locations, primarily in India, and certain tax benefits recognized in the first half of 2014 as a result of the lapse of a statute of limitations.

Net income. As a result of the foregoing factors, net income decreased by $14.0 million from $113.7 million in the first half of 2013 to $99.8 million in the first half of 2014. As a percentage of net revenues, our net income decreased from 10.9% in the first half of 2013 to 9.2% in the first half of 2014.

Net income attributable to noncontrolling interest. Noncontrolling interest primarily refers to profit or loss associated with our noncontrolling partners’ interest in the operations of Genpact Netherlands B.V. and the noncontrolling shareholders’ interest in the operations of Hello Communications (Shanghai) Co., Ltd. Net income attributable to noncontrolling interest decreased from $3.1 million in the first half of 2013 to $0.2 million in the first half of 2014. This decrease was primarily attributable to our purchase of certain partners’ interests in Genpact Netherlands B.V, which reduced the noncontrolling partners’ total interest in the operation of Genpact Netherlands B.V., and to our divestiture of Hello Communications (Shanghai) Co. Ltd. in the first half of 2013.

Net income attributable to Genpact Limited common shareholders. As a result of the foregoing factors, net income attributable to our common shareholders decreased by $11.0 million from $110.6 million in the first half of 2013 to $99.6 million in the first half of 2014. As a percentage of net revenues, net income attributable to Genpact Limited common shareholders decreased from 10.6% in the first half of 2013 to 9.1% in the first half of 2014.

Liquidity and Capital Resources

Overview

Information about our financial position as of December 31, 2013 and June 30, 2014 is presented below:


	As of December 31, 2013		As of June 30, 2014		Percentage change Increase/(Decrease)
	(dollars in millions)
Cash and cash equivalents	$	571.3	$	376.8		(34.0	)%
Long-term debt due within one year		4.3		4.3		0.3
Long-term debt other than the current portion		653.6		651.5		(0.3	)
Genpact Limited total shareholders’ equity	$	1,322.7	$	1,205.7		(8.8	)%

Financial Condition

We finance our operations and our expansion, including acquisitions, with cash from operations and borrowing facilities.

Our cash and cash equivalents were $376.8 million as of June 30, 2014, compared to $571.3 million as of December 31, 2013. Our cash and cash equivalents as of June 30, 2014 were comprised of (a) $78.0 million in cash in current accounts across all operating locations to be used for working capital and immediate capital requirements, (b) $298.0 million in deposits with banks to be used for medium-term planned expenditure and capital requirements and (c) $0.8 million in restricted cash balances. Restrictions primarily consist of margin balances against bank guarantees and deposits for foreign currency advances on which the bank has created a lien.

As of June 30, 2014, $370.0 million of the $376.8 million of cash and cash equivalents was held by our foreign (non-Bermuda) subsidiaries. We intend to either permanently reinvest $345.0 million of the cash held by our foreign subsidiaries or expect to be able to repatriate it in a tax-free manner. We have accrued taxes on the remaining cash of $25.0 million held by our foreign subsidiaries. The amount of cash that can be repatriated in a tax-free manner is not ascertainable.

We expect that in the future our cash from operations, cash reserves and debt capacity will be sufficient to finance our operations as well as our growth and expansion. Our working capital needs are primarily to finance our payroll and other administrative and information technology expenses in advance of the receipt of accounts receivable. Our capital requirements include opening new service delivery centers and financing acquisitions.

Cash flows from operating, investing and financing activities, as reflected in our consolidated statements of cash flows, are summarized in the following table:


	Six Months Ended June 30,						Percentage change Increase/(Decrease)
	2013			2014			2013 vs. 2014
	(dollars in million)
Net cash provided by (used for)
Operating activities	$	107.7		$	93.1			(13.6	)%
Investing activities		(72.5	)		(153.2	)		111.2
Financing activities		41.6			(141.8	)		(440.7	)
Net increase (decrease) in cash and cash equivalents	$	76.8		$	(202.0	)		(363.1	)%

Cash flows from operating activities. Our net cash generated from operating activities was $93.1 million in the first half of 2014, compared to $107.7 million in the first half of 2013. This decrease was primarily a result of a $20.1 million decrease in net income adjusted for amortization, depreciation and other non-cash items in the first half of 2014 compared to the first half of 2013. Further, up-front investments in certain large deals resulted in an additional cash outflow of $6.5 million in the first half of 2014 compared to the first half of 2013. This increased outflow was partially offset by a higher proportion of client receivables collected in the first half of 2014 compared to the first half of 2013, resulting in a $10.4 million lower investment in accounts receivable.

Cash flows from investing activities. Our net cash used for investing activities was $153.2 million in the first half of 2014, compared to $72.5 million in the first half of 2013. This increase in net cash used for investing activities was primarily due to the payment of $123.7 million, net of cash acquired, for our regulatory affairs acquisition in the first half of 2014 compared to the payment of $46.1 million in the first half of 2013, net of cash acquired, for our acquisitions of the Jawood Business and NGEN. The balance of the increase in net cash used for investing activities was due to higher payments for purchases of property, plant and equipment (net of sales proceeds) of $29.5 million in the first half of 2014 compared to $25.4 million in the first half of 2013.

Cash flows from financing activities. Our net cash used for financing activities was $141.8 million in the first half of 2014 compared to net cash provided by financing activities of $41.6 million in the first half of 2013. This change was primarily due to the payment of $302.6 million for the purchase of Company common shares and related expenses of $2.5 million in the first half of 2014. Lower proceeds from the issuance of common shares under stock-based compensation plans in the first half of 2014 also accounted for a $19.1 million reduction in cash inflows in the first half of 2014 compared to the first half of 2013. Additionally, payments for net settlement of stock-based awards were $6.8 million higher in the first half of 2014 than in the first half of 2013. The impact of these items on cash flows was offset by higher proceeds from short-term borrowings (net of repayments) of $175.0 million in the first half of 2014 compared to $35.0 million in the first half of 2013 and by the payment of $7.9 million in expenses relating to the amendment of our credit facility in the first half of 2013.

Financing Arrangements (Credit Facility)

Our credit agreement provides for a term loan of $675.0 million. Total long-term debt, excluding capital lease obligations, was $655.7 million as of June 30, 2014, compared to $657.9 million as of December 31, 2013.

We finance our short-term working capital requirements through cash flows from operations and credit facilities from banks and financial institutions. As of June 30, 2014, short-term credit facilities available to the Company, which are governed by the same agreement as our long-term credit facility, aggregated $250.0 million. As of June 30, 2014, a total of $2.2 million and $175.0 million were utilized, representing non-funded and funded drawdown, respectively.

Our credit facility will expire in August 2017. The funded drawdown amount bears interest at LIBOR plus a margin of 2.50% as of both December 31, 2013 and June 30, 2014. The unutilized amount on the facility bears a commitment fee of 0.50%. Indebtedness under these facilities is secured by certain assets of the Company, and the credit agreement contains certain covenants, including a maximum leverage covenant that becomes effective only if the revolving facility is drawn for $50.0 million or more. During the six months ended June 30, 2014, the Company was in compliance with all of the financial covenants.

In addition, we have fund-based and non-fund-based credit facilities with banks, which are available for operational requirements in the form of overdrafts, letters of credit, guarantees and short-term loans. As of June 30, 2014, the limit available was $14.1 million, out of which a total of $7.5 million, constituting non-funded drawdown, was utilized.

Off-Balance Sheet Arrangements

Our off-balance sheet arrangements consist of foreign exchange contracts and certain operating leases. For additional information, see Part1, Item 1A—Risk Factors—“Currency exchange rate fluctuations in various currencies in which we do business, especially the Indian rupee and the U.S. dollar, could have a material adverse effect on our business, results of operations and financial condition” in our Annual Report on Form 10-K for the year ended December 31, 2013, the section titled “Contractual Obligations” below and note 7 in Part I—Financial Statements.

Contractual Obligations

The following table sets forth our total future contractual obligations as of June 30, 2014:


	Total		Less than 1 year		1-3 years		3-5 years		After 5 years
	(dollars in million)
Long-term debt	$	775.3	$	27.9	$	55.2	$	54.3	$	637.9
- Principal payments		655.7		4.3		8.6		8.7		634.1
- Interest payments*		119.6		23.6		46.6		45.6		3.8
Capital leases		5.7		2.1		2.8		0.8		—
- Principal payments		4.6		1.6		2.3		0.6		—
- Interest payments		1.1		0.6		0.4		0.1		—
Operating leases		154.2		37.9		58.8		34.7		22.7
Purchase obligations		23.1		23.1		—		—		—
Capital commitments, net of advances		6.1		6.1		—		—		—
Earn-out Consideration		29.7		13.4		16.3		—		—
- Reporting Date Fair Value		24.9		12.2		12.7		—		—
- Interest		4.8		1.3		3.5		—		—
Other long-term liabilities		142.1		74.2		66.2		1.7		0.03

Total contractual cash obligations	$	1,136.1	$	184.8	$	199.2	$	91.4	$	660.6

*	Our interest payments on long-term debt represent estimated cash interest payments based on the prevailing interest rate as of June 30, 2014.

Recent Accounting Pronouncements

Recently adopted accounting pronouncements

For a description of recently adopted accounting pronouncements, see Note 2—“Recently adopted accounting pronouncements” under Item 1—“Financial Statements” above and Part II, Item 7—“Management’s Discussion and Analysis of Financial Condition and Results of Operations”— “Critical Accounting Policies and Estimates” in our Annual Report on Form 10-K for the year ended December 31, 2013.

Recently issued accounting pronouncements

In May, 2014, the FASB issued Accounting Standards Update (“ASU”) No. 2014-09, Revenue from Contracts with Customers, which will replace most existing revenue recognition guidance in U.S. GAAP. The core principle of the ASU is that an entity should recognize revenue for the transfer of goods or services equal to the amount that it expects to be entitled to receive for those goods or services. The ASU requires additional disclosure about the nature, amount, timing and uncertainty of revenue and cash flows arising from customer contracts, including significant judgments and changes in judgments. The ASU will be effective for us beginning January 1, 2017, including interim periods in our fiscal year 2017, and allows for both retrospective and prospective adoption. We are in the process of determining the method of adoption and assessing the impact of this ASU on our Consolidated Financial Statements.

In April 2014, FASB issued ASU No. 2014-08, Reporting Discontinued Operations and Disclosures of Disposals of Components of an Entity, which changes the criteria for reporting discontinued operations and requires additional disclosures about discontinued operations. The ASU requires an entity to report as a discontinued operation only a disposal that represents a strategic shift in its operations that has a major effect on it operational and financial results. The ASU will be effective for us beginning January 1, 2015, including interim periods in our fiscal year 2015, and does not allow for retrospective adoption. Early application is permitted, but only for those disposals (or classifications as held-for-sale) that have not been reported in financial statements previously issued or available for issuance. We do not expect the adoption of this update to have a material impact on our consolidated results of operations, cash flows, financial position or disclosures.

In June 2014, FASB issued ASU No. 2014-12, Accounting for Share-Based Payments When the Terms of an Award Provide That a Performance Target Could be Achieved after the Requisite Service Period, which requires an entity to treat a performance target that affects vesting and that could be achieved after the requisite service period as a performance condition. The ASU will be effective for us beginning January 1, 2016, including interim periods in our fiscal year 2016. Early adoption and retrospective application are permitted. We do not expect the adoption of this update to have a material impact on our consolidated results of operations, cash flows, financial position or disclosures.

Item 3.

Quantitative and Qualitative Disclosures About Market Risk

During the six months ended June 30, 2014, there were no material changes in our market risk exposure. For a discussion of our market risk associated with foreign currency risk, interest rate risk and credit risk, see Part II, item 7A “Quantitative and Qualitative Disclosures about Market Risk” in our Annual Report on Form 10-K for the year ended December 31, 2013.

Item 4.

Controls and Procedures

Evaluation of Disclosure Controls and Procedures

Disclosure controls and procedures are the Company’s controls and other procedures which are designed to ensure that information required to be disclosed by us in the reports that we file or submit under the Exchange Act is recorded, processed, summarized and reported, within the time periods specified in the SEC’s rules and forms. Disclosure controls and procedures include, without limitation, controls and procedures designed to ensure that information required to be disclosed by us in the reports that we file or submit under the Securities Exchange Act of 1934 (the “Exchange Act”) is accumulated and communicated to our management, including our Chief Executive Officer and Chief Financial Officer, as appropriate, to allow timely decisions regarding required disclosure.

As of the end of the period covered by this report, the Company carried out an evaluation, under the supervision and with the participation of the Company’s management, including the Company’s Chief Executive Officer and the Company’s Chief Financial Officer, of the effectiveness of the design and operation of the Company’s disclosure controls and procedures pursuant to Exchange Act Rule 13a-15(b). Based upon that evaluation, the Company’s Chief Executive Officer and the Company’s Chief Financial Officer concluded that the Company’s disclosure controls and procedures are effective in timely alerting them to material information relating to the Company (including its consolidated subsidiaries) required to be included in the Company’s periodic SEC filings.

Changes in Internal Control Over Financial Reporting

There were no changes in the Company’s internal control over financial reporting (as defined in Rules 13a-15(f) and 15d-15(f) under the Exchange Act) during the quarter ended June 30, 2014 that have materially affected, or are reasonably likely to materially affect, the Company’s internal control over financial reporting.

In making its assessment of the changes in internal controls over financial reporting during the quarter ended June 30, 2014, our management excluded an evaluation of the disclosure controls and procedures of companies acquired in the six months ended June 30, 2014. See Note 3 to the Unaudited Consolidated Financial Statements for a discussion of these acquisitions.

PART II

Item 1.

Legal Proceedings

There are no legal proceedings pending against us that we believe are likely to have a material adverse effect on our business, results of operations and financial condition.

Item 1A.

Risk Factors

We have disclosed under the heading “Risk Factors” in our Annual Report on Form 10-K for the year ended December 31, 2013 the risk factors that materially affect our business, financial condition or results of operations. You should carefully consider the “Risk Factors” set forth in our Annual Report on Form 10-K for the year ended December 31, 2013, the risk factors set forth below and the other information that appears elsewhere in this Quarterly Report on Form 10-Q. You should be aware that these risk factors and other information may not describe every risk facing our Company. Additional risks and uncertainties not currently known to us also may materially adversely affect our business, financial condition and/or results of operations.

Tax matters, new legislation and actions by taxing authorities may have an adverse effect on our operations, effective tax rate and financial condition.

We are subject to income taxes in the United States and numerous foreign jurisdictions. Our tax expense and cash tax liability in the future could be adversely affected by numerous factors, including, but not limited to, changes in tax laws, regulations, accounting principles or interpretations and the potential adverse outcome of tax examinations and pending tax-related litigation. Changes in the valuation of deferred tax assets and liabilities, which may result from a decline in our profitability or changes in tax rates or legislation, could have a material adverse effect on our tax expense. The governments of foreign jurisdictions from which we deliver services may assert that certain of our clients have a “permanent establishment” in such foreign jurisdictions by reason of the activities we perform on their behalf, particularly those clients that exercise control over or have substantial dependency on our services. Such an assertion could affect the size and scope of the services requested by such clients in the future.

The Government of India had served notice on the Company about its potential liability, as a representative assessee of GE, for Indian tax upon GE’s 2004 transfer of shares of a predecessor of the Company. GE challenged the positions of the Government of India in the Delhi High Court, naming Genpact India (one of our subsidiaries) as a necessary party but without seeking relief against Genpact India. We believe that if Indian tax were due upon that transfer, it could not be successfully asserted against us as a representative assessee. Moreover, GE is obligated to indemnify us for any tax on its 2004 transfer of shares. On August 12, 2011, the Delhi High Court ruled that Genpact India cannot be held to be a representative assessee in this transaction. The tax authorities have filed an appeal with the Supreme Court of India against this ruling, which is pending.

In respect of certain of our transactions, including our acquisitions (which included our subsidiaries organized under Indian law or owning assets located there), internal reorganizations, the sale of our shares in our public offerings or otherwise by our existing significant shareholders, the Indian tax authorities may argue that Indian tax is chargeable in as much as indirect transfers of Indian subsidiaries or assets are involved in such transactions and may seek to impose tax on us directly or as a withholding agent or representative assessee of the sellers.

In 2012, the Government of India enacted legislation purporting to clarify the intent of existing tax law (and hence the law applicable in prior periods) to tax “all income accruing or arising, whether directly or indirectly, through or from any business connection in India, or through or from any property in India, or through or from any asset or source of income in India, or through the transfer of a capital asset situate in India.” The legislation, which we refer to as the Indirect Transfer Rule, also provides that an “asset or a capital asset being any share or interest in a company or entity registered or incorporated outside India shall be deemed to be situated in India, if the share or interest derives, directly or indirectly, its value substantially from the assets located in India.” “Substantially” has not been defined for purposes of the Indirect Transfer Rule. Public commentary on the legislation, including statements by various officials of the Government of India, has suggested that the legislation was intended to allow for the taxation of indirect transfer of shares in an Indian company, possibly with retrospective effect. The full implications and scope of this legislation, and how its provisions will be interpreted and applied are presently unclear, but arguably could apply to certain transactions involving the Company as noted above.

Because there are significant uncertainties relating to the application of the Indirect Transfer Rule to transactions in shares of non-Indian companies, such as the Company, that have significant assets and operations in India, it is not clear whether, or to what extent, a buyer of any shares issued by the Company could be held liable for not withholding Indian tax on the acquisition of such shares or be subject to Indian tax on gains realized on the disposition of shares of the Company.

In addition, the Government of India issued an assessment order to the Company in May 2014 seeking to assess tax on certain transactions that occurred in 2009 and 2010. The Company believes that the transactions should not be subject to tax in India, primarily as a result of the relief provided under the Mauritius-India Treaty, and has filed an appeal. The Company has received a demand for the potential tax claim as a result of the assessment for $43 million, including interest, and may be required to pay some or all of this amount to the Indian tax authority in 2014 under protest pending the resolution of the matter. There is no assurance that the Company’s position will prevail, and a final determination of tax in the amounts claimed could have a material adverse effect on our results of operations, effective tax rate and financial condition.

Furthermore, the Governments of India, the United States or other jurisdictions could enact new tax legislation, including anti-avoidance provisions, which would have a material adverse effect on our business, results of operations and financial condition. In 2012, the Indian government enacted anti-avoidance provisions, which are now proposed to be implemented with effect from April 1, 2015 onwards. The full implications and scope of the new anti-avoidance provisions, if implemented, as well as how these changes may apply to us, are presently unclear. More recently, the Indian government has enacted changes to taxation on distributions from Indian companies. Our ability to repatriate surplus earnings from our subsidiaries in a tax-efficient manner is dependent upon interpretations of local laws, further possible changes in such laws and the renegotiation of existing double tax avoidance treaties. Changes to any of these may adversely affect our overall tax rate or the cost of our services to our clients, or impose additional levels of tax upon us, any of which could have a material adverse effect on our business, results of operations and financial condition.

Item 2.

Unregistered Sales of Equity Securities and Use of Proceeds

Unregistered Sales of Equity Securities

None.

Use of Proceeds

None.

Purchase of Equity Securities by the Issuer and Affiliated Purchasers

Share purchase activity during the three months ended June 30, 2014 was as follows:


Period	Total Number of Shares Purchased		Average Price Paid per Share ($)		Total Number of Shares Purchased as Part of Publicly Announced Plans or Programs		Maximum Approximate Dollar Value of Shares that May Yet Be Purchased Under the Plans or Programs (a)
April 1 – April 30, 2014		17,292,842		17.5		17,292,842		—

(a)

On April 8, 2014, we purchased 17,292,842 of our common shares at $17.50 per share for an aggregate cash amount of approximately $302.6 million pursuant to our modified “Dutch Auction” self-tender offer announced on March 5, 2014. Under the terms of the offer, we had the right to purchase up to $300 million in value of our common shares. The number of shares we accepted for purchase included the partial exercise of our right to upsize the offer by up to 2% of our common shares then outstanding.

Item 3.

Defaults Upon Senior Securities

None.

Item 5.

Other Information

None.

Item 6.

Exhibits



3.1		Memorandum of Association of the Registrant (incorporated by reference to Exhibit 3.1 to Amendment No. 2 of the Registrant’s Registration Statement on Form S-1 (File No. 333-142875) filed with the SEC on July 16, 2007).

3.3		Bye-laws of the Registrant (incorporated by reference to Exhibit 3.3 to Amendment No. 4 of the Registrant’s Registration Statement on Form S-1 (File No. 333-142875) filed with the SEC on August 1, 2007).

10.1		Form of Director Indemnity Agreement*

10.2		Employment Agreement by and between the Company and Edward J. Fitzpatrick, dated as of June 26, 2014 (incorporated by reference to Exhibit 10.1 to the Current Report on Form 8-K (File No. 001-33626) filed with the SEC on July 2, 2014).

10.3		Form of Share Option Agreement with Edward J. Fitzpatrick (incorporated by reference to Exhibit 10.2 to the Current Report on Form 8-K (File No. 001-33626) filed with the SEC on July 2, 2014).



10.4		Form of RSU Award Agreement with Edward J. Fitzpatrick (incorporated by reference to Exhibit 10.3 to the Current Report on Form 8-K (File No. 001-33626) filed with the SEC on July 2, 2014).

31.1		Certification of the Chief Executive Officer pursuant to Rule 13a-14(a) or 15d-14(a) of the Securities Exchange Act of 1934, as adopted pursuant to Section 302 of the Sarbanes-Oxley Act of 2002.*

31.2		Certification of the Chief Financial Officer pursuant to Rule 13a-14(a) or 15d-14(a) of the Securities Exchange Act of 1934, as adopted pursuant to Section 302 of the Sarbanes-Oxley Act of 2002.*

32.1		Certification of the Chief Executive Officer pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002.*

32.2		Certification of the Chief Financial Officer pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002.*

101.INS		XBRL Instance Document (1)

101.SCH		XBRL Taxonomy Extension Schema Document (1)

101.CAL		XBRL Taxonomy Extension Calculation Linkbase Document (1)

101.DEF		XBRL Taxonomy Extension Definition Linkbase Document (1)

101.LAB		XBRL Taxonomy Extension Label Linkbase Document (1)

101.PRE		XBRL Taxonomy Extension Presentation Linkbase Document (1)

*	Filed with this Quarterly Report on Form 10-Q.

(1)

Attached as Exhibit 101 to this report are the following documents formatted in XBRL (Extensible Business Reporting Language): (i) Consolidated Balance Sheets as of December 31, 2013 and June 30, 2014, (ii) Consolidated Statements of Income for the three months and six months ended June 30, 2013 and June 30, 2014, (iii) Consolidated Statements of Comprehensive Income (Loss) for the three months and six months ended June 30, 2013 and June 30, 2014, (iv) Consolidated Statements of Equity for the six months ended June 30, 2013 and 2014, (v) Consolidated Statements of Cash Flows for the six months ended June 30, 2013 and June 30, 2014, and (vi) Notes to the Consolidated Financial Statements.

SIGNATURES

Pursuant to the requirements of Section 13 or 15(d) of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.

Date: August 8, 2014

GENPACT LIMITED


By:		/s/ N.V. TYAGARAJAN
		N.V. Tyagarajan
		Chief Executive Officer

By:		/s/ EDWARD J. FITZPATRICK
		Edward J. Fitzpatrick
		Chief Financial Officer

EXHIBIT INDEX


Exhibit Number		Description

3.1		Memorandum of Association of the Registrant (incorporated by reference to Exhibit 3.1 to Amendment No. 2 of the Registrant’s Registration Statement on Form S-1 (File No. 333-142875) filed with the SEC on July 16, 2007).

3.3		Bye-laws of the Registrant (incorporated by reference to Exhibit 3.3 to Amendment No. 4 of the Registrant’s Registration Statement on Form S-1 (File No. 333-142875) filed with the SEC on August 1, 2007).

10.1		Form of Director Indemnity Agreement*

10.2		Employment Agreement, by and between the Company and Edward J. Fitzpatrick, dated as of June 26, 2014 (incorporated by reference to Exhibit 10.1 to the Current Report on Form 8-K (File No. 001-33626) filed with the SEC on July 2, 2014).

10.3		Form of Share Option Agreement with Edward J. Fitzpatrick (incorporated by reference to Exhibit 10.2 to the Current Report on Form 8-K (File No. 001-33626) filed with the SEC on July 2, 2014).

10.4		Form of RSU Award Agreement with Edward J. Fitzpatrick (incorporated by reference to Exhibit 10.3 to the Current Report on Form 8-K (File No. 001-33626) filed with the SEC on July 2, 2014).

31.1		Certification of the Chief Executive Officer pursuant to Rule 13a-14(a) or 15d-14(a) of the Securities Exchange Act of 1934, as adopted pursuant to Section 302 of the Sarbanes-Oxley Act of 2002.*

31.2		Certification of the Chief Financial Officer pursuant to Rule 13a-14(a) or 15d-14(a) of the Securities Exchange Act of 1934, as adopted pursuant to Section 302 of the Sarbanes-Oxley Act of 2002.*

32.1		Certification of the Chief Executive Officer pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002.*

32.2		Certification of the Chief Financial Officer pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002.*

101.INS		XBRL Instance Document (1)

101.SCH		XBRL Taxonomy Extension Schema Document (1)

101.CAL		XBRL Taxonomy Extension Calculation Linkbase Document (1)

101.DEF		XBRL Taxonomy Extension Definition Linkbase Document (1)

101.LAB		XBRL Taxonomy Extension Label Linkbase Document (1)

101.PRE		XBRL Taxonomy Extension Presentation Linkbase Document (1)

*	Filed with this Quarterly Report on Form 10-Q.

(1)

EX-10.1

Exhibit 10.1

INDEMNITY AGREEMENT

This Indemnification Agreement (“Agreement”) is made as of , 20 , by and between Genpact Limited, an exempted limited company organized under the laws of Bermuda (“Company”) and (“Indemnitee”).

RECITALS

WHEREAS, highly competent persons have become more reluctant to serve publicly-held corporations as directors or in other capacities unless they are provided with adequate protection through insurance and/or adequate indemnification against inordinate risks of claims and actions against them arising out of their service to and activities on behalf of such corporations;

WHEREAS, the Amended and Restated Memorandum of Association (the “Charter”) and Amended and Restated Bye-laws (the “Bye-laws”) of the Company provide for indemnification of the officers and directors of the Company, and Indemnitee may also be entitled to indemnification pursuant to the Companies Act 1981 (Bermuda) as amended (“BCA”);

WHEREAS, the Board of Directors of the Company (the “Board”) has determined that, in order to attract and retain qualified individuals, the Company will attempt to maintain on an ongoing basis, at its sole expense, liability insurance to protect persons serving the Company and its subsidiaries from certain liabilities;

WHEREAS, the uncertainties relating to such insurance and to indemnification have increased the difficulty of attracting and retaining such persons;

WHEREAS, the Board has determined that the increased difficulty in attracting and retaining such persons is detrimental to the best interests of the Company and its shareholders and that the Company should act to assure such persons that there will be increased certainty of such protection in the future;

WHEREAS, it is reasonable, prudent, necessary and in the best interests of the Company contractually to obligate itself to indemnify, and to advance expenses on behalf of, such persons to the fullest extent permitted by applicable law so that they will serve or continue to serve the Company free from undue concern that they will not be so indemnified;

WHEREAS, this Agreement is a supplement to and in furtherance of the Charter and Bye-Laws of the Company and any resolutions adopted pursuant thereto and any liability insurance, and shall not be deemed a substitute therefor, nor to diminish or abrogate any rights of Indemnitee thereunder;

WHEREAS, Indemnitee does not regard the protection available under the Company’s Charter, Bye-Laws and insurance as adequate in the present circumstances, and may not be willing to serve as an officer or director without adequate protection, and the Company desires Indemnitee to serve in such capacity, Indemnitee is willing to serve, continue to serve and to take on additional service for or on behalf of the Company on the condition that [he][she] be so indemnified;

NOW, THEREFORE, in consideration of the promises and the covenants contained herein, the Company and Indemnitee do hereby covenant and agree as follows:

1. Services to the Company. Indemnitee will serve or continue to serve, at the will of the Company, as an officer, director or key employee of the Company for so long as Indemnitee is duly elected or appointed or until Indemnitee tenders [his][her] resignation or is otherwise removed as an officer, director or key employee; however, this Agreement shall not impose any obligation on Indemnitee or the Company to continue Indemnitee’s service to the Company beyond any period otherwise required by law or by other agreements or commitments of the parties, if any.

2. Definitions. As used in this Agreement

(a) “Change of Control” shall mean the occurrence of any of the following events, not including any events occurring prior to or in connection with the initial public offering of shares (including the occurrence of such initial public offering):

(i)

during any period of 24 consecutive months, individuals who were members of the Board at the beginning of such period (the “Incumbent Directors”) cease at any time during such period for any reason to constitute at least a majority of the Board; provided, however, that (A) any individual becoming a director subsequent to the beginning of such period whose appointment or election, or nomination for election, by the Company’s shareholders was approved by a vote of at least a majority of the Incumbent Directors shall be considered as though such individual were an Incumbent Director, but excluding, for purposes of this proviso, any such individual whose initial assumption of office occurs pursuant to an actual or threatened proxy contest with respect to election or removal of directors or other actual or threatened solicitation of proxies or consents by or on behalf of any “person” (as such term is used in Section 13(d) of the Exchange Act), other than the Board and (B) any individual becoming a director subsequent to the beginning of such period whose nomination for election was designated by any of the Specified Shareholders and made by the Nominating and Governance Committee of the Board (or any successor committee thereto), in each case, pursuant to the Shareholder Agreement, shall be considered as though such individual were an Incumbent Director;

(ii)

the consummation of (A) an amalgamation, consolidation, statutory share exchange, reorganization, recapitalization, tender offer or similar form of corporate transaction involving (x) the Company or (y) any of its subsidiaries, but in the case of this clause (y) only if Company Voting Securities (as defined below) are issued or issuable in

-2-

connection with such transaction (each of the transactions referred to in this clause (A), being hereinafter referred to as a “Reorganization”) or (B) a sale or other disposition of all or substantially all the assets of the Company (a “Sale”), unless, immediately following such Reorganization or Sale, (1) all or substantially all the individuals and entities who were the “beneficial owners” (as such term is defined in Rule 13d-3 under the Exchange Act (or a successor rule thereto)) of the Company’s common shares or other securities eligible to vote for the election of the Board (such securities, the “Company Voting Securities”) outstanding immediately prior to the consummation of such Reorganization or Sale beneficially own, directly or indirectly, more than 50% of the combined voting power of the then outstanding voting securities of the corporation or other entity resulting from such Reorganization or Sale (including a corporation or other entity that, as a result of such transaction, owns the Company or all or substantially all the Company’s assets either directly or through one or more subsidiaries) (the “Continuing Entity”) in substantially the same proportions as their ownership, immediately prior to the consummation of such Reorganization or Sale, of the outstanding Company Voting Securities (excluding any outstanding voting securities of the Continuing Entity that such beneficial owners hold immediately following the consummation of such Reorganization or Sale as a result of their ownership prior to such consummation of voting securities of any corporation or other entity involved in or forming part of such Reorganization or Sale other than the Company or a subsidiary), (2) no Person (excluding any employee benefit plan (or related trust) sponsored or maintained by the Continuing Entity or any corporation or other entity controlled by the Continuing Entity) beneficially owns, directly or indirectly, securities representing a percentage of the combined voting power of the then outstanding voting securities of the Continuing Entity that is equal to or greater than (x) in the case of the Specified Shareholders, 50% (in the aggregate for all Specified Shareholders) or (y) in the case of any Person other than any Specified Shareholder, 25%, and (3) at least a majority of the members of the board of directors or other governing body of the Continuing Entity were Incumbent Directors at the time of the execution of the definitive agreement providing for such Reorganization or Sale or, in the absence of such an agreement, at the time at which approval of the board of directors was obtained for such Reorganization or Sale;

(iii)

the shareholders of the Company approve a voluntary plan of liquidation, winding up or dissolution of the Company, unless such liquidation, winding up or dissolution is part of a transaction or series of transactions described in paragraph (ii) above that does not otherwise constitute a Change of Control; or

-3-

(iv)

any Person, corporation or other entity or group (within the meaning of Section 13(d)(3) or 14(d)(2) of the Exchange Act) becomes the beneficial owner, directly or indirectly, of securities of the Company representing a percentage of the combined voting power of the Company Voting Securities that is equal to or greater than (x) in the case of the Specified Shareholders (or any group including any Specified Shareholder), 50% (in the aggregate for all Specified Shareholders and all such groups) or (y) in the case of any Person other than any Specified Shareholder (or any group not including any Specified Shareholder), 25%; provided, however, that for purposes of this subparagraph (iv) (and not for purposes of subparagraphs (i) through (iii) above), the following acquisitions shall not constitute a Change of Control: (A) any acquisition by the Company or any subsidiary, (B) any acquisition by any employee benefit plan (or related trust) sponsored or maintained by the Company or any subsidiary, (C) any acquisition by an underwriter temporarily holding such Company Voting Securities pursuant to an offering of such securities, (D) any acquisition pursuant to a Reorganization or Sale that does not constitute a Change of Control for purposes of subparagraph (ii) above or (E) any acquisition directly from the Company.

(b) “Company” means Genpact Limited and its successors, and shall include, in the case of any merger, amalgamation or consolidation, in addition to the resulting corporation and surviving corporation, any constituent corporation (including any constituent of a constituent) absorbed in such consolidation, amalgamation or merger which, if its separate existence had continued, would have had power and authority to indemnify its directors, officers, employees, trustees, fiduciaries or agents, so that if Indemnitee is or was a director, officer, employee, trustee, fiduciary or agent of such constituent corporation, or is or was serving at the request of such constituent corporation as a director, officer, employee, trustee, fiduciary or agent of another corporation, partnership, joint venture, trust, employee benefit program or other enterprise, Indemnitee shall stand in the same position under the provisions of this Agreement with respect to the resulting or surviving corporation as Indemnitee would have with respect to such constituent corporation if its separate existence had continued.

(c) “Corporate Status” describes the status of a person who is or was a director, officer, employee, agent, trustee or fiduciary of the Company or of any other corporation, partnership, joint venture, trust, employee benefit plan or other enterprise which such person is or was serving at the request of the Company.

(d) “Disinterested Director” means a director of the Company who is not and was not a party to the Proceeding in respect of which indemnification is sought by Indemnitee.

(e) “Enterprise” means the Company and any other company, corporation, partnership, joint venture, trust, employee benefit plan or other enterprise of which Indemnitee is or was serving at the request of the Company as a director, officer, employee, agent, trustee or fiduciary.

-4-

(f) “Expenses” means all retainers, court costs, transcript costs, fees of experts, witness fees, private investigators, travel expenses, duplicating costs, printing and binding costs, telephone charges, postage, fax transmission charges, secretarial services, delivery service fees, reasonable attorneys’ fees, and all other disbursements or expenses of the types customarily and properly incurred in connection with prosecuting, defending, preparing to prosecute or defend, investigating, being or preparing to be a witness in, or otherwise participating in, a Proceeding or in connection with seeking indemnification under this Agreement. Expenses also shall include Expenses incurred in connection with any appeal resulting from any Proceeding, including without limitation the premium, security for, and other costs relating to any cost bond, supersedeas bond, or other appeal bond or its equivalent. Expenses, however, shall not include amounts paid in settlement by Indemnitee or the amount of judgments or fines against Indemnitee.

(g) “Independent Counsel” means a law firm, or a member of a law firm, that is experienced in matters of relevant corporation law and neither presently is, nor in the past five years has been, retained to represent: (i) the Company or Indemnitee in any matter material to either such party (other than with respect to matters concerning Indemnitee under this Agreement, or of other indemnitees under similar indemnification agreements), or (ii) any other party to the Proceeding giving rise to a claim for indemnification hereunder. Notwithstanding the foregoing, the term “Independent Counsel” shall not include any person who, under the applicable standards of professional conduct then prevailing, would have a conflict of interest in representing either the Company or Indemnitee in an action to determine Indemnitee’s rights under this Agreement.

(h) “Losses” means all loss, liability, judgments, damages, amounts paid in settlement, fines, penalties, interest, assessments, other charges or, with respect to an employee benefit plan, excise taxes or penalties assessed with respect thereto.

(i) References to “other enterprise” shall include employee benefit plans; references to “fines” shall include any excise tax assessed with respect to any employee benefit plan; references to “serving at the request of the Company” shall include any service as a director, officer, employee, trustee, fiduciary or agent of the Company which imposes duties on, or involves services by, such director, officer, employee, trustee, fiduciary or agent with respect to an employee benefit plan, its participants or beneficiaries; and a person who acted in good faith and in a manner [he][she] reasonably believed to be in the best interests of the participants and beneficiaries of an employee benefit plan shall be deemed to have acted in a manner not opposed to the best interests of the Company and not in “bad faith” as referred to under applicable law.

(j) “Person” means an individual, entity, partnership, limited liability company, corporation, association, joint stock company, trust, joint venture, unincorporated organization, and a governmental entity or any department agency or political subdivision thereof.

-5-

(k) The term “Proceeding” shall include any threatened, pending or completed action, suit, arbitration, alternate dispute resolution mechanism, investigation, inquiry, administrative hearing or any other actual, threatened or completed proceeding, including any and all appeals, whether brought in the right of the Company or otherwise and whether of a civil, criminal, administrative or investigative nature and whether formal or informal, in which Indemnitee was, is or will be involved as a party or otherwise by reason of or relating to the fact that Indemnitee is or was a director, officer, employee, agent, trustee or fiduciary of the Company, by reason of or relating to any action taken by [him][her] or of any action on [his][her] part while acting as director, officer, employee, agent, trustee or fiduciary of the Company, or by reason of the fact that [he][she] is or was serving at the request of the Company as a director, officer, employee, agent, trustee or fiduciary of another Enterprise, in each case whether or not serving in such capacity at the time any Loss or Expense is incurred for which indemnification, reimbursement, or advancement of Expenses can be provided under this Agreement, including one initiated by an Indemnitee to enforce [his][her] rights under this Agreement.

(l) “Shareholder Agreement” means the Amended and Restated Shareholder Agreement, dated as of October 25, 2012, by and among Genpact Limited, Glory Investments A Limited, Glory Investments B Limited, Glory Investments IV Limited, Glory Investments IV-B Limited, RGIP, LLC and Twickenham Investment Private Limited, as such agreement may be further amended and restated, amended, supplemented or otherwise modified from time to time.

(m) “Specified Shareholder” means Bain Capital Investors, LLC, Bain Capital Partners, LLC or any entity that directly or indirectly, through one or more intermediaries, is controlled by Bain Capital Investors, LLC or Bain Capital Partners, LLC. As used in this Agreement, “control” means the possession, directly or indirectly, of the power to direct or cause the direction of the management and policies of such entity, whether through ownership of voting securities or other interests, by contract or otherwise. Neither the Company nor any of its Subsidiaries shall be deemed to be a “Specified Shareholder” for any reason under this Agreement.

(n) For purposes of Sections 3 and 4, the meaning of the phrase “to the fullest extent permitted by law” shall include, but not be limited to:

to the fullest extent permitted by the BCA, and

to the fullest extent authorized or permitted by any amendments to or replacements of the BCA adopted after the date of this Agreement that increase the extent to which a corporation may indemnify its officers, directors, employees, agents, trustees, fiduciaries and other persons acting or serving at the Company’s request.

3. Indemnity in Third-Party Proceedings. The Company shall indemnify Indemnitee in accordance with the provisions of this Section 3 if Indemnitee was or is, or was or is threatened to be made, a party to or a witness or participant in any Proceeding, other than a Proceeding by or in the right of the Company to procure a judgment in its favor. Pursuant to this Section 3, Indemnitee shall be indemnified against all Expenses and Losses to the fullest extent permitted by law.

-6-

4. Indemnity in Proceedings by or in the Right of the Company. The Company shall indemnify Indemnitee in accordance with the provisions of this Section 4 if Indemnitee was or is, or was or is threatened to be made, a party to or a participant in any Proceeding by or in the right of the Company to procure a judgment in its favor. Pursuant to this Section 4, Indemnitee shall be indemnified against all Expenses and Losses actually and reasonably incurred or suffered by [him][her] or on [his][her] behalf in connection with such Proceeding or any claim, issue or matter therein to the fullest extent permitted by law. No indemnification for Expenses or Losses shall be made under this Section 4 in respect of any claim, issue or matter as to which Indemnitee shall have been finally adjudged by a court to be liable to the Company, unless and only to the extent that a court of appropriate jurisdiction shall determine upon application that, despite the adjudication of liability but in view of all the relevant circumstances of the case, Indemnitee is fairly and reasonably entitled to indemnification, but any such indemnification shall be limited to Expenses.

5. Indemnification for Expenses of a Party Who is Wholly or Partly Successful. Notwithstanding any other provisions of this Agreement, to the extent that Indemnitee was or is a party to (or a participant in) and is successful, on the merits or otherwise, in defense of any Proceeding or in defense of any claim, issue or matter therein, in whole or in part, the Company shall indemnify Indemnitee against all Expenses actually and reasonably incurred by [him][her] in connection therewith. If Indemnitee is not wholly successful in such Proceeding but is successful, on the merits or otherwise, as to one or more but less than all claims, issues or matters in such Proceeding, the Company shall indemnify Indemnitee against all Expenses actually and reasonably incurred by [him][her] or on [his][her] behalf in connection with each successfully resolved claim, issue or matter and any claim, issue or matter related to any claim, issue, or matter on which Indemnitee was successful. For purposes of this Section and without limitation, the termination of any claim, issue or matter in such a Proceeding by dismissal, with or without prejudice, shall be deemed to be a successful result as to such claim, issue or matter.

6. Indemnification For Expenses of a Witness. Notwithstanding any other provision of this Agreement, to the extent that Indemnitee is, by reason of [his][her] Corporate Status, a witness in any Proceeding to which Indemnitee is not a party, [he][she] shall be indemnified against all Expenses actually and reasonably incurred by [him][her] or on [his][her] behalf in connection therewith.

7. Exclusions. Notwithstanding any provision in this Agreement to the contrary, the Company shall not be obligated under this Agreement to make any indemnity in connection with any claim made against Indemnitee:

(a) for which payment has actually been made to or on behalf of Indemnitee under any insurance policy or other indemnity provision, except with respect to any excess beyond the amount paid under any insurance policy or other indemnity provision; or

(b) for an accounting of profits made from the purchase and sale (or sale and purchase) by Indemnitee of securities of the Company within the meaning of Section 16(b) of the Securities Exchange Act of 1934, as amended, or similar provisions of state statutory law or common law; or

-7-

(c) in connection with any Proceeding (or any part of any Proceeding) initiated or brought voluntarily by Indemnitee prior to a Change of Control against the Company or its directors, officers, employees or other indemnitees, unless (i) the Board of the Company authorized the Proceeding (or any part of any Proceeding) prior to its initiation, or (ii) the Company provides indemnification, in its sole discretion, pursuant to the powers vested in the Company under applicable law.

8. Advances of Expenses. Notwithstanding any provision of this Agreement to the contrary, the Company shall advance the Expenses reasonably incurred by Indemnitee in connection with any Proceeding for which indemnification is or may be available pursuant to this Agreement within 20 days after the receipt by the Company of a statement or statements requesting such advances from time to time, whether prior to or after final disposition of any Proceeding. Advances shall be unsecured and interest free. Advances shall be made to the fullest extent permitted by applicable law and without requiring a preliminary determination of Indemnitee’s ultimate entitlement to indemnification under the other provisions of this Agreement, including any determination under Section 11 hereof. Advances shall include any and all Expenses incurred pursuing an action to enforce this right of advancement, including Expenses incurred preparing and forwarding statements to the Company to support the advances claimed. Indemnitee shall qualify for advances solely upon the execution and delivery to the Company of (a) a written affirmation by Indemnitee of Indemnitee’s good faith belief that the standard of conduct necessary for indemnification by the Company as authorized by law and by this Agreement has been met and (b) a written undertaking by or on behalf of Indemnitee to repay any Expenses advanced if it shall ultimately be determined that such standard of conduct has not been met.

9. Selection of Counsel. In the event the Company is obligated under Section 8 hereof to pay, and pays the Expenses of any Proceeding against Indemnitee, the Company, if appropriate, shall be entitled to assume the defense of such Proceeding, with counsel approved by Indemnitee, which approval shall not be unreasonably withheld, upon the delivery to Indemnitee of written notice of its election so to do. After delivery of such notice, approval of such counsel by Indemnitee and the retention of such counsel by the Company, the Company will not be liable to Indemnitee under this Agreement for any fees of counsel subsequently incurred by Indemnitee with respect to the same Proceeding, provided that (i) Indemnitee shall have the right to employ [his][her] counsel in any such Proceeding at Indemnitee’s expense; and (ii) if (A) the employment of counsel by Indemnitee has been previously authorized by the Company, (B) Indemnitee shall have reasonably concluded that there may be a conflict of interest between the Company and Indemnitee in the conduct of any such defense or (C) the Company shall not, in fact, have employed counsel approved by Indemnitee to assume the defense of such Proceeding, then the fees and expenses of Indemnitee’s counsel shall be at the expense of the Company.

-8-

10. Procedure for Notification and Defense of Claim.

(a) Indemnitee shall, as a condition precedent to [his][her] right to be indemnified under this Agreement, give the Company notice in writing as soon as practicable of any claim made against Indemnitee for which indemnification will or could be sought under this Agreement; provided, however, that a delay in giving such notice shall not deprive Indemnitee of any right to be indemnified under this Agreement unless, and then only to the extent that, such delay is materially prejudicial to the defense of such claim. The omission to notify the Company will not relieve the Company from any liability for indemnification which it may have to Indemnitee otherwise under this Agreement. The Secretary of the Company shall, promptly upon receipt of such a request for indemnification, advise the Board in writing that Indemnitee has requested indemnification.

(b) The Company will be entitled to participate in any Proceeding at its own expense.

11. Procedure Upon Application for Indemnification.

(a) Following written request by Indemnitee for indemnification pursuant to the first sentence of Section 10(a), a determination, if required by applicable law, with respect to Indemnitee’s entitlement thereto shall be made in the specific case: (i) if a Change of Control shall have occurred, by Independent Counsel in a written opinion to the Board, a copy of which shall be delivered to Indemnitee; or (ii) if a Change of Control shall not have occurred, (A) by the Board by a majority vote of a quorum consisting of Disinterested Directors, (B) if such a quorum cannot be obtained then by a majority vote of a committee of the Board consisting solely of Disinterested Directors designated by a majority vote of the Board in which directors who are parties to the Proceeding in respect of which indemnification is sought may participate, (C) if a quorum of the Board consisting of Disinterested Directors is not obtainable, and if a majority vote of a committee of the Board consisting solely of Disinterested Directors is not obtainable, or, even if obtainable such quorum of Disinterested Directors, or such committee, by a majority vote so directs, by Independent Counsel in a written opinion to the Board, a copy of which shall be delivered to Indemnitee or (D) if so directed by a majority of the members of the Board, by the shareholders of the Company; and, if it is so determined that Indemnitee is entitled to indemnification, payment to Indemnitee shall be made within ten (10) days after such determination. Indemnitee shall cooperate with the person, persons or entity making such determination with respect to Indemnitee’s entitlement to indemnification, including providing to such person, persons or entity upon reasonable advance request any documentation or information which is not privileged or otherwise protected from disclosure and which is reasonably available to Indemnitee and reasonably necessary to such determination. Any costs or expenses (including attorneys’ fees and disbursements) incurred by Indemnitee in so cooperating with the person, persons or entity making such determination shall be borne by the Company (irrespective of the determination as to Indemnitee’s entitlement to indemnification) and the Company hereby indemnifies and agrees to hold Indemnitee harmless therefrom.

(b) In the event the determination of entitlement to indemnification is to be made by Independent Counsel pursuant to Section 11(a) hereof, the Independent Counsel shall be selected as provided in this Section 11(b). If a Change of Control shall not have occurred, the Independent Counsel shall be selected by the Board or a committee of the

-9-

Board consisting solely of Disinterested Directors, by the vote required by applicable law for the selection of Independent Counsel, and the Company shall give written notice to Indemnitee advising [him][her] of the identity of the Independent Counsel so selected. If a Change of Control shall have occurred, the Independent Counsel shall be selected by Indemnitee (unless Indemnitee shall request that such selection be made by the Board, in which event the preceding sentence shall apply), subject to approval by the Board, or a committee thereof consisting solely of Disinterested Directors, by the vote required by applicable law for the selection of Independent Counsel, and Indemnitee shall give written notice to the Company advising it of the identity of the Independent Counsel so selected. Any such approval by the Board or a committee thereof consisting solely of Disinterested Directors, will not be unreasonably withheld and by such approval the Board or committee shall be deemed to have joined in such selection. In either event, Indemnitee or the Company, as the case may be, may, within ten (10) days after such written notice of selection shall have been given, deliver to the Company or to Indemnitee, as the case may be, a written objection to such selection; provided, however, that such objection may be asserted only on the ground that the Independent Counsel so selected does not meet the requirements of “Independent Counsel” as defined in Section 2 of this Agreement, and the objection shall set forth with particularity the factual basis for such assertion. Absent a proper and timely objection, the person so selected (and, if a Change of Control shall have occurred, approved by the Board or a committee thereof consisting solely of Disinterested Directors) shall act as Independent Counsel. If such written objection is so made and substantiated, the Independent Counsel so selected may not serve as Independent Counsel unless and until such objection is withdrawn or a court has determined that such objection is without merit. If, within twenty (20) days after submission by Indemnitee of a written request for indemnification pursuant to Section 10(a) hereof, no Independent Counsel shall have been selected (and, if a Change of Control shall have occurred, approved by the Board or a committee thereof consisting solely of Disinterested Directors) and not objected to, either the Company or Indemnitee may petition a court of competent jurisdiction for resolution of any failure by the Board or a committee thereof to approve Indemnitee’s selection of Independent Counsel after a Change of Control shall have occurred, or any objection which shall have been made by the Company or Indemnitee to the other’s selection of Independent Counsel and/or for the appointment as Independent Counsel of a person selected by the court or by such other person as the court shall designate, and the person with respect to whom all failures to approve and objections are so resolved or the person so appointed shall act as Independent Counsel under Section 11(a) hereof. Upon the due commencement of any judicial proceeding or arbitration pursuant to Section 13(a) of this Agreement, Independent Counsel shall be discharged and relieved of any further responsibility in such capacity (subject to the applicable standards of professional conduct then prevailing).

-10-

12. Presumptions and Effect of Certain Proceedings.

(a) In making a determination with respect to entitlement to indemnification hereunder, the person or persons or entity making such determination shall presume that Indemnitee is entitled to indemnification under this Agreement and the Company shall have the burden of proof to overcome that presumption in connection with the making by any person, persons or entity of any determination contrary to that presumption. Neither the failure of the Company (including by its directors or independent legal counsel) to have made a determination prior to the commencement of any action pursuant to this Agreement that indemnification is proper in the circumstances because Indemnitee has met the applicable standard of conduct, nor an actual determination by the Company (including by its directors or independent legal counsel) that Indemnitee has not met such applicable standard of conduct, shall be a defense to the action or create a presumption that Indemnitee has not met the applicable standard of conduct.

(b) If the person, persons or entity empowered or selected under Section 11 of this Agreement to determine whether Indemnitee is entitled to indemnification shall not have made a determination within sixty (60) days after receipt by the Company of the request therefor, the requisite determination of entitlement to indemnification shall be deemed to have been made and Indemnitee shall be entitled to such indemnification, absent (i) a misstatement by Indemnitee of a material fact, or an omission of a material fact necessary to make Indemnitee’s statement not materially misleading, in connection with the request for indemnification or (ii) a prohibition of such indemnification under applicable law; provided, however, that such 60-day period may be extended for a reasonable time, not to exceed an additional thirty (30) days or, if later, 30 days following final disposition (including termination) of the applicable Proceeding, if the person, persons or entity making the determination with respect to entitlement to indemnification in good faith requires such additional time for the obtaining or evaluating of documentation and/or information relating thereto; and provided, further, that the foregoing provisions of this Section 12(b) shall not apply if the determination of entitlement to indemnification is to be made by Independent Counsel pursuant to Section 11(a) of this Agreement.

(c) Termination. The termination of any proceeding by judgment, order or settlement does not create a presumption that Indemnitee did not meet the requisite standard of conduct required under applicable law for indemnification.

(d) Actions of Others. The knowledge and/or actions, or failure to act, of any director, officer, agent, trustee, fiduciary or employee of the Enterprise shall not be imputed to Indemnitee for purposes of determining the right to indemnification under this Agreement.

13. Remedies of Indemnitee.

(a) In the event that (i) a determination is made pursuant to Section 11 of this Agreement that Indemnitee is not entitled to indemnification under this Agreement, (ii) advancement of Expenses is not timely made pursuant to Section 8 of this Agreement, (iii) no determination of entitlement to indemnification shall have been made pursuant to Section 11(a) of this Agreement within sixty (60) days after proper receipt by the Company of the request for indemnification (or such later period as provided under Section 12(b)), or (iv) payment of indemnification is not made pursuant to Section 3, 4, 5, 6 or the last sentence of Section 11(a) of this Agreement within ten (10) days after receipt

-11-

by the Company of a written request therefor, or, if a determination is required by law, within ten (10) days after a determination has been made that Indemnitee is entitled to indemnification, Indemnitee shall be entitled to an adjudication (or, in the case of clause (i), to seek an adjudication) in an appropriate court of the State of New York or in any other court of competent jurisdiction of [his][her] entitlement to such indemnification or advancement of Expenses; provided, that nothing contained in this Section 13 shall be deemed to limit Indemnitee’s rights under Section 12(b). Alternatively, Indemnitee, at [his][her] option, may seek an award in binding arbitration to be conducted by a single arbitrator pursuant to the Commercial Arbitration Rules of the American Arbitration Association. The Company shall not oppose Indemnitee’s right to seek any such adjudication or award in arbitration.

(b) In the event that a determination shall have been made pursuant to Section 11(a) of this Agreement that Indemnitee is not entitled to indemnification, any judicial proceeding or arbitration commenced pursuant to this Section 13 shall be conducted in all respects as a de novo trial or arbitration on the merits, and Indemnitee shall not be prejudiced by reason of that adverse determination. In any judicial proceeding or arbitration commenced pursuant to this Section 13 the Company shall have the burden of proving Indemnitee is not entitled to indemnification or advancement of Expenses, as the case may be.

(c) If a determination shall have been made pursuant to Section 11(a) of this Agreement that Indemnitee is entitled to indemnification, the Company shall be bound by such determination in any judicial proceeding or arbitration commenced pursuant to this Section 13, absent (i) a misstatement by Indemnitee of a material fact, or an omission of a material fact necessary to make Indemnitee’s statement not materially misleading, in connection with the request for indemnification or (ii) a prohibition of such indemnification under applicable law.

(d) The Company shall be precluded from asserting in any judicial proceeding or arbitration commenced pursuant to this Section 13 that the procedures and presumptions of this Agreement are not valid, binding and enforceable and shall stipulate in any such court or before any such arbitrator that the Company is bound by all the provisions of this Agreement. The Company shall indemnify Indemnitee against any and all Expenses, and if requested by Indemnitee, shall (within twenty (20) days after receipt by the Company of a written request therefore) advance such expenses to Indemnitee, which are incurred by Indemnitee in connection with any action brought by Indemnitee for indemnification or advance of Expenses from the Company under this Agreement, under the Company’s Charter and Bye-Laws as in effect from time to time or under any directors’ and officers’ liability insurance policies maintained by the Company, regardless of whether Indemnitee ultimately is determined to be entitled to such indemnification, advancement of Expenses or insurance recovery, as the case may be.

-12-

14. Non-exclusivity; Survival of Rights; Insurance; Subrogation.

(a) The rights of indemnification and to receive advancement of Expenses as provided by this Agreement shall not be deemed exclusive of any other rights to which Indemnitee may at any time be entitled under applicable law, the Charter, Bye-Laws, any agreement, a vote of shareholders or a resolution of directors, or otherwise. No amendment, alteration or repeal of this Agreement or of any provision hereto shall limit or restrict any right of Indemnitee under this Agreement in respect of any action taken or omitted by such Indemnitee in [his][her] Corporate Status prior to such amendment, alteration or repeal. To the extent that a change in Bermuda law, whether by statute or judicial decision, permits greater indemnification or advancement of Expenses than would be afforded currently under the Charter, Bye-Laws and this Agreement, it is the intent of the parties hereto that Indemnitee shall enjoy by this Agreement the greater benefits so afforded by such change. No right or remedy herein conferred is intended to be exclusive of any other right or remedy, and every other right and remedy shall be cumulative and in addition to every other right and remedy given hereunder or now or hereafter existing at law or in equity or otherwise. The assertion or employment of any right or remedy hereunder, or otherwise, shall not prevent the concurrent assertion or employment of any other right or remedy.

(b) The Company shall, from time to time, make the good faith determination whether or not it is practicable for the Company to obtain and maintain a policy or policies of insurance with reputable insurance companies providing the directors, officers, employees, trustees, fiduciaries and agents of the Company with coverage for losses from wrongful acts, or to ensure the Company’s performance of its indemnification obligations under this Agreement. Among other considerations, the Company will weigh the costs of obtaining such insurance coverage against the protection afforded by such coverage. To the extent that the Company maintains an insurance policy or policies providing liability insurance for directors, officers, employees, trustees, fiduciaries and agents of the Company or of any other corporation, partnership, joint venture, trust, employee benefit plan or other enterprise which such person serves at the request of the Company, Indemnitee shall be covered by such policy or policies in accordance with its or their terms to the maximum extent of the coverage available for any such director, officer, employee, trustee, fiduciary or agent under such policy or policies. If, at the time of the receipt of a notice of a claim pursuant to the terms hereof, the Company has director and officer liability insurance in effect, the Company shall give prompt notice of the commencement of such proceeding to the insurers in accordance with the procedures set forth in the respective policies. The Company shall thereafter take all necessary or desirable action to cause such insurers to pay, on behalf of Indemnitee, all amounts payable as a result of such proceeding in accordance with the terms of such policies.

(c) In the event of any payment under this Agreement, the Company shall be subrogated to the extent of such payment to all of the rights of recovery of Indemnitee against other persons or entities, and Indemnitee shall execute all papers required and take all action necessary to secure such rights, including execution of such documents as are necessary to enable the Company to bring suit to enforce such rights.

-13-

(d) The Company shall not be liable under this Agreement to make any payment of amounts otherwise indemnifiable (or for which advancement is provided hereunder) hereunder if and to the extent that Indemnitee has otherwise actually received such payment under any insurance policy, contract, agreement or otherwise.

(e) The Company’s obligation to indemnify or advance Expenses hereunder to Indemnitee who is or was serving at the request of the Company as a director, officer, employee, trustee, fiduciary or agent of any other corporation, partnership, joint venture, trust, employee benefit plan or other enterprise shall be reduced by any amount Indemnitee has actually received as indemnification or advancement of expenses from such other corporation, partnership, joint venture, trust, employee benefit plan or other enterprise.

(f) [The Company hereby acknowledges that Indemnitee may have certain rights to indemnification, advancement of expenses and/or insurance provided by the Specified Shareholders. The Company hereby agrees that, notwithstanding any other provision of this Agreement (including, without limitation, the provisions set forth in Sections 7(a), 14(c), 14(d) and 14(e)), (i) the obligations of the Company to Indemnitee under this Agreement, the Charter, the Bye-Laws and any resolutions adopted pursuant to the Charter and the Bye-Laws to advance Expenses or to provide indemnification for Expenses or Losses in connection with any Proceeding are primary and any obligation of any Specified Shareholder to advance such Expenses or provide such indemnification, and any claims under any insurance policy maintained by any Specified Shareholder (any such policy, a “Specified Shareholder Insurance Policy”) covering such Expenses or Losses in connection with any Proceeding, are secondary, (ii) any rights Indemnitee may have against any Specified Shareholder or under any Specified Shareholder Insurance Policy, and any advancement or payment made by any Specified Shareholder (or under any Specified Shareholder Insurance Policy) on behalf of Indemnitee in connection with any Proceeding, shall be disregarded when determining the full amount of all Expenses and Losses the Company is obligated to indemnify under this Agreement, the Charter, the Bye-Laws and any resolutions adopted pursuant to the Charter and the Bye-Laws, and (iii) the Company waives and releases each Specified Shareholder from any and all claims against such Specified Shareholder for contribution for or recovery of any Expenses or Losses the Company is obligated to indemnify under this Agreement, the Charter, the Bye-Laws or any resolutions adopted pursuant to the Charter and the Bye-Laws. For the avoidance of doubt, each Specified Shareholder shall be an express third-party beneficiary of this Section 14(f).]¹

15. Settlement.

(a) The Company shall have no obligation to indemnify Indemnitee under this Agreement for any amounts paid in settlement of any Proceeding by Indemnitee effected without the Company’s prior written consent.

¹	Section 14(f) is included only in indemnity agreements for directors who are nominees of a Specified Shareholder.

-14-

(b) The Company shall not, without the prior written consent of Indemnitee, consent to the entry of any judgment against Indemnitee or enter into any settlement or compromise which (i) includes an admission of fault of Indemnitee, any non-monetary remedy affecting or obligation of Indemnitee, or monetary Loss for which Indemnitee is not indemnified hereunder or (ii) with respect to any Proceeding with respect to which Indemnitee may be or is made a party, witness or participant or may be or is otherwise entitled to seek indemnification hereunder, does not include, as an unconditional term thereof, the full release of Indemnitee from all liability in respect of such Proceeding, which release shall be in form and substance reasonably satisfactory to Indemnitee.

16. Duration of Agreement. This Agreement shall continue until and terminate upon the later of (a) ten (10) years after the date that Indemnitee shall have ceased to serve as a director or officer of the Company or as a director, officer, employee, trustee, fiduciary or agent of any other corporation, partnership, joint venture, trust, employee benefit plan or other enterprise which Indemnitee served at the request of the Company or (b) one (1) year after the final termination of any Proceeding, including any and all appeals, then pending in respect of which Indemnitee is granted rights of indemnification or advancement of Expenses hereunder and of any proceeding commenced by Indemnitee pursuant to Section 13 of this Agreement relating thereto.

17. Successors and Assigns. This Agreement shall be binding upon the Company and its successors and assigns and shall inure to the benefit of Indemnitee and [his][her] heirs, executors and administrators.

18. Severability. If any provision or provisions of this Agreement shall be held to be invalid, illegal or unenforceable for any reason whatsoever (a) the validity, legality and enforceability of the remaining provisions of this Agreement (including without limitation, each portion of any Section of this Agreement containing any such provision held to be invalid, illegal or unenforceable, that is not itself invalid, illegal or unenforceable) shall not in any way be affected or impaired thereby and shall remain enforceable to the fullest extent permitted by law; (b) such provision or provisions shall be deemed reformed to the extent necessary to conform to applicable law and to give the maximum effect to the intent of the parties hereto; and (c) to the fullest extent possible, the provisions of this Agreement (including, without limitation, each portion of any Section of this Agreement containing any such provision held to be invalid, illegal or unenforceable, that is not itself invalid, illegal or unenforceable) shall be construed so as to give effect to the intent manifested thereby.

19. Enforcement.

(a) The Company expressly confirms and agrees that it has entered into this Agreement and assumed the obligations imposed on it hereby in order to induce Indemnitee to serve as a director or officer of the Company, and the Company acknowledges that Indemnitee is relying upon this Agreement in serving as a director or officer of the Company.

-15-

(b) This Agreement constitutes the entire agreement between the parties hereto with respect to the subject matter hereof and supersedes all prior agreements and understandings, oral, written and implied, between the parties hereto with respect to the subject matter hereof.

20. Effectiveness of Agreement. This Agreement shall be effective as of the date set forth on the first page and may apply to acts or omissions of Indemnitee which occurred prior to such date if Indemnitee was an officer, director, employee, trustee, fiduciary or other agent of the Company, or was serving at the request of the Company as a director, officer, employee, trustee, fiduciary or agent of another corporation, partnership, joint venture, trust, employee benefit plan or other enterprise, at the time such act or omission occurred.

21. Modification and Waiver. No supplement, modification or amendment of this Agreement shall be binding unless executed in writing by the parties thereto. No waiver of any of the provisions of this Agreement shall be deemed or shall constitute a waiver of any other provisions of this Agreement nor shall any waiver constitute a continuing waiver.

22. Notice by Indemnitee. Indemnitee agrees promptly to notify the Company in writing upon being served with any summons, citation, subpoena, complaint, indictment, information or other document relating to any Proceeding or matter which may be subject to indemnification or advancement of Expenses covered hereunder. The failure of Indemnitee to so notify the Company shall not relieve the Company of any obligation which it may have to Indemnitee under this Agreement or otherwise.

23. Notices. All notices, requests, demands and other communications under this Agreement shall be in writing and shall be deemed to have been duly given (a) if delivered by hand and receipted for by the party to whom said notice or other communication shall have been directed, or (b) mailed by certified or registered mail with postage prepaid, on the third business day after the date on which it is so mailed:

(a) If to Indemnitee, at the address indicated on the signature page of this Agreement, or such other address as Indemnitee shall provide to the Company.

-16-

(b) If to the Company to

Genpact Limited

c/o Genpact LLC

1155 Avenue of the Americas, 4^th Floor

New York, NY 10036

Attention: General Counsel

With a copy to:

Genpact Limited

Canon’s Court

22 Victoria Street

Hamilton HM 12

Bermuda

Attention: The Secretary

or to any other address as may have been furnished to Indemnitee by the Company.

24. Contribution. To the fullest extent permissible under applicable law, if the indemnification provided for in this Agreement is unavailable to Indemnitee for any reason whatsoever, the Company, in lieu of indemnifying Indemnitee, shall contribute to the amount incurred by Indemnitee, whether for Losses and/or for Expenses, in connection with any claim relating to an indemnifiable event under this Agreement, in such proportion as is deemed fair and reasonable in light of all of the circumstances of such Proceeding in order to reflect (i) the relative benefits received by the Company and Indemnitee as a result of the event(s) and/or transaction(s) giving cause to such Proceeding; and/or (ii) the relative fault of the Company (and its directors, officers, employees, trustees, fiduciaries and agents) and Indemnitee in connection with such event(s) and/or transaction(s).

25. Applicable Law and Consent to Jurisdiction. This Agreement and the legal relations among the parties shall be governed by, and construed and enforced in accordance with, the laws of the State of New York.

26. Identical Counterparts. This Agreement may be executed in one or more counterparts, each of which shall for all purposes be deemed to be an original but all of which together shall constitute one and the same Agreement. Only one such counterpart signed by the party against whom enforceability is sought needs to be produced to evidence the existence of this Agreement.

27. Miscellaneous. Use of the masculine pronoun shall be deemed to include usage of the feminine pronoun where appropriate. The headings of the paragraphs of this Agreement are inserted for convenience only and shall not be deemed to constitute part of this Agreement or to affect the construction thereof. The term including shall mean including without limitation.

-17-

IN WITNESS WHEREOF, the parties have caused this Agreement to be signed as of the day and year first above written.


GENPACT LIMITED						INDEMNITEE
By:						By:
Name:						Name:
						Address:

-18-

EX-31.1

Exhibit 31.1

CHIEF EXECUTIVE OFFICER CERTIFICATION

I, N.V. Tyagarajan, certify that:

I have reviewed this Quarterly Report on Form 10-Q of Genpact Limited for the period ended June 30, 2014, as filed with the Securities and Exchange Commission on the date hereof;

Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;

Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report;

The registrant’s other certifying officer and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have:

Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;

Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;

Evaluated the effectiveness of the registrant’s disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and

Disclosed in this report any change in the registrant’s internal control over financial reporting that occurred during the registrant’s most recent fiscal quarter (the registrant’s fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant’s internal control over financial reporting; and

The registrant’s other certifying officer(s) and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant’s auditors and the audit committee of the registrant’s board of directors (or persons performing the equivalent functions):

All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant’s ability to record, process, summarize and report financial information; and

Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant’s internal control over financial reporting.

Date: August 8, 2014

/s/ N.V. TYAGARAJAN

N.V. Tyagarajan

Chief Executive Officer

EX-31.2

Exhibit 31.2

CHIEF FINANCIAL OFFICER CERTIFICATION

I, Edward J. Fitzpatrick, certify that:

I have reviewed this Quarterly Report on Form 10-Q of Genpact Limited for the period ended June 30, 2014, as filed with the Securities and Exchange Commission on the date hereof;

Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant’s internal control over financial reporting.

Date: August 8, 2014

/S/ EDWARD J. FITZPATRICK

Edward J. Fitzpatrick

Chief Financial Officer

EX-32.1

Exhibit 32.1

Certification of the Chief Executive Officer

Pursuant to 18 U.S.C. Section 1350,

As Adopted Pursuant to Section 906 of the Sarbanes-Oxley Act of 2002

In connection with the Quarterly Report of Genpact Limited (the “Company”) on Form 10-Q for the period ended June 30, 2014 as filed with the Securities and Exchange Commission on the date hereof (the “Report”), I, N.V. Tyagarajan, Chief Executive Officer of the Company, certify, pursuant to 18 U.S.C. §1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, that:

1. The Report fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934; and

2. The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company.

Date: August 8, 2014

/S/ N.V. TYAGARAJAN

N.V. Tyagarajan

Chief Executive Officer

Genpact Limited

EX-32.2

Exhibit 32.2

Certification of the Chief Financial Officer

Pursuant to 18 U.S.C. Section 1350,

As Adopted Pursuant to Section 906 of the Sarbanes-Oxley Act of 2002

In connection with the Quarterly Report of Genpact Limited (the “Company”) on Form 10-Q for the period ended June 30, 2014 as filed with the Securities and Exchange Commission on the date hereof (the “Report”), I, Edward J. Fitzpatrick, Chief Financial Officer of the Company, certify, pursuant to 18 U.S.C. §1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, that:

1. The Report fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934; and

2. The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company.

Date: August 8, 2014

/S/ EDWARD J. FITZPATRICK

Edward J. Fitzpatrick

Chief Financial Officer
Genpact Limited